11,014 results on '"Liping AN"'
Search Results
2. Effects of light intensity and photoperiod on the growth and stress response of juvenile Nile tilapia (Oreochromis niloticus) in a recirculating aquaculture system
- Author
-
Liping Liu, Rainier Mols, Kang Li, Kui Wang, Cristina Tanase, and Michiel van der Meer
- Subjects
photoperiodism ,0303 health sciences ,food.ingredient ,Ecology ,biology ,business.industry ,Fish farming ,Recirculating aquaculture system ,Tilapia ,04 agricultural and veterinary sciences ,Aquatic Science ,biology.organism_classification ,03 medical and health sciences ,Oreochromis ,Light intensity ,Nile tilapia ,Animal science ,food ,Aquaculture ,040102 fisheries ,0401 agriculture, forestry, and fisheries ,business ,Ecology, Evolution, Behavior and Systematics ,030304 developmental biology - Abstract
Light is an essential natural factor of fish growth and development. A light regime in indoor aquaculture is critical for sustainable fish production. This research aimed to investigate the effect of light intensity and photoperiod on the growth performance and stress response of Nile tilapia (Oreochromis niloticus), which is an important commercial species, in a recirculating aquaculture system (RAS). Fingerlings with an average weight of 5 ± 0.9 g were randomly assigned to nine 1.5 m3 tanks with 145 fish in each tank, cultured under different light intensities (1000, 2000, and 3000 lx) and photoperiods (12L:12D, 18L:6D, 24L:0D), and fed to apparent satiation twice a day for 160 days. The growth of tilapia subjected to 2000 lx was significantly better than that exposed to 1000 and 3000 lx (P 0.05). Light intensity and photoperiod manipulation did not cause a significant chronic stress response in tilapia. This study demonstrated that light intensity, especially at 2000 lx, and photoperiod manipulation could stimulate the growth of tilapia in the RAS and significantly affect economic profitability. This study also served as an important reference for tilapia indoor aquaculture.
- Published
- 2023
- Full Text
- View/download PDF
3. Expression of HER2 and BRCA1 Correlates with Prognosis in Patients with Breast Cancer After Radiotherapy: A Case–Control Study
- Author
-
Liping Zhou, Yanna Su, and Ye He
- Subjects
Pharmacology ,Oncology ,Cancer Research ,medicine.medical_specialty ,Messenger RNA ,business.industry ,medicine.medical_treatment ,Case-control study ,General Medicine ,medicine.disease ,law.invention ,Radiation therapy ,Radiation sensitivity ,Breast cancer ,law ,Internal medicine ,medicine ,Immunohistochemistry ,Radiology, Nuclear Medicine and imaging ,skin and connective tissue diseases ,business ,Polymerase chain reaction ,Survival analysis - Abstract
Background: This study aims to explore the associations of human epidermal growth factor receptor 2 (HER2) and breast cancer susceptibility gene 1 (BRCA1) expression levels with prognosis and radiation sensitivity in patients with breast cancer. Methods: Breast cancer tissues, adjacent normal breast tissues, and benign breast lesions were initially obtained from 256 breast cancer patients as well as an additional 245 patients with breast lesions. Reverse transcriptase-quantitative polymerase chain reaction (RT-qPCR) was conducted to assess the expression of HER2 and BRCA1 in the collected tissues. Immunohistochemistry was performed to examine HER2 and BRCA1-positive expression levels in the tissues. The relationship between HER2 and BRCA1 expression levels and radiation sensitivity as well breast cancer prognosis was assessed by the Spearman correlation analysis and Kaplan-Meier survival analysis. Results: Compared with adjacent normal breast tissues and benign breast lesions, the breast cancer tissues exhibited high expression of HER2 mRNA and protein and low expression of BRCA1 mRNA and protein. Patients with positive HER2 expression had a significantly shorter survival time, and survival time of patients with positive BRCA1 expression was markedly longer, which were consistent with RT-qPCR results. After radiotherapy, the local failure rate of HER2-positive patients was higher than that of the negative ones, while that of BRCA1-positive patients was lower than that of the negative ones. Conclusions: This study suggested that breast cancer patients with high HER2 expression and low BRCA1 expression were less sensitive to radiotherapy with poor prognosis in breast cancer.
- Published
- 2022
- Full Text
- View/download PDF
4. Predictive Value of the ABCD3-I for Short- and Long-Term Stroke after TIA with or without sICAS
- Author
-
Yilong Wang, Yuesong Pan, Aoming Jin, Yong Jiang, Xuewei Xie, Xia Meng, Zixiao Li, Yongjun Wang, Pan Chen, Jing Jing, Liping Liu, Hao Li, and Xingquan Zhao
- Subjects
medicine.medical_specialty ,business.industry ,Proportional hazards model ,Biochemistry (medical) ,Hazard ratio ,Area under the curve ,medicine.disease ,Risk Assessment ,Predictive value ,Outcome parameter ,Stroke ,Stenosis ,Ischemic Attack, Transient ,Risk Factors ,Internal medicine ,Internal Medicine ,Cardiology ,Humans ,Medicine ,In patient ,Registries ,cardiovascular diseases ,Cardiology and Cardiovascular Medicine ,business - Abstract
Aims We aimed to validate the predictive value of the ABCD3-I score for short-term and long-term stroke risk after transient ischemic attack (TIA) and to evaluate the influence of symptomatic intracranial artery stenosis (sICAS) on the performance of ABCD3-I. Methods We recruited TIA patients from the Third China National Stroke Registry study. Outcome parameters were stroke events during the 14-day, 3-month, 6-month, and 12-month points. The area under the curve (AUC) was calculated as a measure of predictive ability. A multivariable-adjusted Cox proportional hazards model was used to assess the hazard ratio of risk factors for stroke. Results Among 986 patients, 3.9%, 5.1%, 6.5 %, and 8.2% of participants experienced a stroke event during the 14-day, 3-month, 6-month, and 12-month points post TIA, respectively. The AUCs of ABCD3-I score for the prediction of stroke were 0.786, 0.732, 0.715, and 0.699 at the 14-day, 3-month, 6-month, and 12-month points, respectively. The AUCs were 0.774, 0.690, 0.617, and 0.611 in patients with sICAS, 0.789, 0.748, and 0.758 and 0.734 in those without sICAS. P values of the interaction between ABCD3-I categories and sICAS were 0.0618 for 14-day, 0.0098 for 3-month, 0.0318 for 6-month, and 0.0294 for 12-month. Conclusions ABCD3-I score performed well in predicting short-term risk of a stroke after an index TIA in patients with or without sICAS. However, the predictive power decayed with the prolonged period, and the decayed extent was more pronounced among those with sICAS. The assessment of sICAS is a non-ignorable item when using the ABCD3-I score for long-term stroke risk prediction in patients with TIA.
- Published
- 2022
- Full Text
- View/download PDF
5. Self-attention negative feedback network for real-time image super-resolution
- Author
-
Marcin Woźniak, Shuqi Chen, Shuai Liu, Xiangbin Liu, and Liping Song
- Subjects
General Computer Science ,Computer science ,business.industry ,Deep learning ,Image map ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,Field (computer science) ,Image (mathematics) ,Recurrent neural network ,Negative feedback ,Key (cryptography) ,Computer vision ,Artificial intelligence ,business ,Network model - Abstract
In the field of real-time image enhancement, image super-resolution (SR) is an important research hotspot. As an image super-resolution method, deep learning can extract more stable and higher level features. However, image super-resolution processing is an ill posed problem. Due to the lack of self-attentional negative feedback mechanism, the existing methods can not better constrain the mapping space from low-resolution image to high-resolution image, so generated high-resolution (HR) image does not conform to human visual perception. Therefore, this paper proposes a self-attention negative feedback network (SRAFBN) for realizing the real-time image SR. The network model constrains the image mapping space and selects the key information of the image through the self-attention negative feedback model, so that higher quality images can be generated to meet human visual perception. Specifically, a Recurrent Neural Network (RNN) is firstly utilized to construct multiple negative feedback modules, and each module generates a HR image. Then, the key information of the generated image is extracted by the self-attention mechanism. Finally, the extracted information is fused to generate the final HR image. Experimental results prove the proposed SRAFBN network model not only has higher PSNR and SSIM, but also can reconstruct more realistic and clear real-time images.
- Published
- 2022
- Full Text
- View/download PDF
6. Xiaoyao Pill Improves the Affective Dysregulation of Sleep-deprived Female Mice by Inhibiting Brain Injury and Regulating the Content of Monoamine Neurotransmitter
- Author
-
Qi Liu, Wei Dandan, Yang Liping, Xinyue Qiao, Shihu Gan, Li Yujie, Huimin Du, Hanbin Liu, Yichi Zhang, Zhang Minghao, Yijie Dong, and Tiantian Yue
- Subjects
Serotonin ,medicine.medical_specialty ,Pharmaceutical Science ,Hippocampus ,Irritability ,Mice ,Internal medicine ,medicine ,Water environment ,Animals ,Prefrontal cortex ,Neurotransmitter Agents ,business.industry ,Body Weight ,Sleep in non-human animals ,Sleep deprivation ,Endocrinology ,Monoamine neurotransmitter ,Brain Injuries ,Pill ,Sleep Deprivation ,Female ,medicine.symptom ,business ,Proto-Oncogene Proteins c-fos ,Drugs, Chinese Herbal ,Biotechnology - Abstract
Background: Sleep curtailment is a serious problem in many societies. Clinical evidence has shown that sleep deprivation is associated with mood dysregulation, formation of false memory, cardio-metabolic risk factors and outcomes, inflammatory disease risk, and all-cause mortality. The affective disorder dysregulation caused by insufficient sleep has become an increasingly serious health problem. However, to date, not much attention has been paid to the mild affective dysregulation caused by insufficient sleep, and there is no clear and standard therapeutic method to treat it. The Xiaoyao Pill is a classic Chinese medicinal formula, with the effect of dispersing stagnated hepatoqi, invigorating the spleen, and nourishing the blood. Therefore, it is most commonly used to treat gynecological diseases in China. In the present study, the effects of the Xiaoyao Pill on affective dysregulation of sleep-deprived mice and its underlying molecular mechanisms were investigated. Methods: Forty adult female mice were used in the present study. The sleep deprivation model was established by improving the multi-platform water environment method. After 7 consecutive days of sleep deprivation, the mice were administrated low (LXYP, 0.32mg/kg) and high (HXYP, 0.64 mg/kg) doses of the Xiaoyao Pill for two weeks. Then, the body weight, behavioral deficits, and histopathology were evaluated. Meanwhile, the expression of c-fos protein and the concentrations of monoamine neurotransmitters in the hippocampus and prefrontal cortex were determined after two weeks of treatment. Results: Xiaoyao Pill treatment significantly increased body weight and sucrose consumption and decreased the irritability scores of the sleep-deprived mice. Meanwhile, Xiaoyao Pill treatment prevented brain injury and inhibited the expression of c-fos protein in the hippocampus and prefrontal cortex. In addition, HXYP treatment significantly upregulated the levels of NE in the hippocampus and prefrontal cortex (p < 0.01). LXYP treatment significantly up-regulated the levels of 5-HT in the prefrontal cortex. Meanwhile, both HXYP and LXYP treatment significantly up-regulated the levels of DA in the prefrontal cortex (p < 0.05 or p < 0.01) of sleep-deprived mice. Conclusions: The present study demonstrates that Xiaoyao Pill treatment prevented the behavioral deficits of mice induced by sleep deprivation by promoting the recovery of brain tissue injury and up-regulating the levels of NE, 5-HT, and DA in the brain tissue.
- Published
- 2022
- Full Text
- View/download PDF
7. Lenses In VoicE (LIVE): searching for strong gravitational lenses in the VOICE@VST survey using convolutional neural networks
- Author
-
Chiara Spiniello, Crescenzo Tortora, Liping Fu, Mattia Vaccari, Nicola R. Napolitano, Zuhui Fan, Giovanni Covone, Dezi Liu, R. Li, Fabrizio Gentile, Léon V. E. Koopmans, Gentile, F., Tortora, C., Covone, G., Koopmans, L. V. E., Spiniello, C., Fan, Z., Li, R., Liu, D., Napolitano, N. R., Vaccari, M., Fu, L., Kapteyn Astronomical Institute, Fabrizio Gentile, Crescenzo Tortora, Giovanni Covone, Léon V E Koopman, Chiara Spiniello, Zuhui Fan, Rui Li, Dezi Liu, Nicola R Napolitano, Mattia Vaccari, and Liping Fu
- Subjects
FOS: Physical sciences ,Astrophysics::Cosmology and Extragalactic Astrophysics ,Convolutional neural network ,cD ,law.invention ,Gravitation ,law ,Observatory ,Computer vision ,galaxies: elliptical and lenticular ,Instrumentation and Methods for Astrophysics (astro-ph.IM) ,Physics ,business.industry ,gravitational lensing: strong ,Astronomy and Astrophysics ,Astrophysics - Astrophysics of Galaxies ,Sample (graphics) ,Galaxy ,Lens (optics) ,Space and Planetary Science ,Limiting magnitude ,Astrophysics of Galaxies (astro-ph.GA) ,galaxies: elliptical and lenticular, cD ,RGB color model ,Artificial intelligence ,Astrophysics - Instrumentation and Methods for Astrophysics ,business - Abstract
We present a sample of 16 likely strong gravitational lenses identified in the VST Optical Imaging of the CDFS and ES1 fields (VOICE survey) using Convolutional Neural Networks (CNNs). We train two different CNNs on composite images produced by superimposing simulated gravitational arcs on real Luminous Red Galaxies observed in VOICE. Specifically, the first CNN is trained on single-band images and more easily identifies systems with large Einstein radii, while the second one, trained on composite RGB images, is more accurate in retrieving systems with smaller Einstein radii. We apply both networks to real data from the VOICE survey, taking advantage of the high limiting magnitude (26.1 in the r-band) and low PSF FWHM (0.8" in the r-band) of this deep survey. We analyse $\sim21,200$ images with $mag_r, 15 pages, 12 figures, submitted to MNRAS
- Published
- 2021
- Full Text
- View/download PDF
8. Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis
- Author
-
Jing Ye, Huixin Shen, Lehong Gao, Liping Li, Chunqiu Fan, and Xiaoqin Huang
- Subjects
Male ,medicine.medical_specialty ,Temporal lobe ,Epilepsy ,Adrenal Cortex Hormones ,Leucine ,Seizures ,Interquartile range ,Limbic Encephalitis ,Glioma ,Internal medicine ,medicine ,Humans ,Immunologic Factors ,Autoantibodies ,Autoimmune encephalitis ,business.industry ,Intracellular Signaling Peptides and Proteins ,Odds ratio ,Middle Aged ,medicine.disease ,Psychiatry and Mental health ,Encephalitis ,Female ,Immunotherapy ,Neurology (clinical) ,business ,Hyponatremia - Abstract
Objective The investigators aimed to explore the clinical characteristics, immunotherapy, and outcomes of patients with antileucine-rich glioma-inactivated-1 (anti-LGI1) encephalitis. Methods Data on participants' clinical characteristics, laboratory findings, radiological and electroencephalogram (EEG) features, treatment, and outcomes from January 2012 to December 2016 were collected. Statistical analysis was conducted to assess the factors associated with patient functional outcome. Forty-three patients were enrolled in the study, with a predominance of males (65.1%). The median age at onset was 57 years (interquartile range [IQR]: 44.0-65.0). The median time from onset to diagnosis was 60 days (IQR: 37.0-127.0). Results The main clinical manifestations included epilepsy (100%), faciobrachial dystonic seizures (FBDS; 44.2%), cognitive dysfunction (95.3%), neuropsychiatric disturbances (76.7%), sleep disorders (58.1%), and disturbance of consciousness (48.8%). Twenty-two patients (51.2%) had hyponatremia, 31 (72.1%) had abnormal EEG results, and 30 (69.8%) had abnormal brain MRI scans, mainly involving the hippocampus (76.7%) or temporal lobe (40%). Twenty of 34 patients (58.8%) in a follow-up MRI examination exhibited hippocampal atrophy. Twenty-five patients (58.2%) were administered corticosteroids and intravenous immunoglobulin, whereas 17 patients were treated only with corticosteroids. Forty-one patients (95.3%) had favorable outcomes after a median of 21.5 months (IQR: 7-43) of follow-up. Serum sodium level was a factor associated with a disabled status (odds ratio=0.81, 95% CI=0.66, 0.98, p=0.03). Anti-LGI1 encephalitis patients were characterized by seizures, FBDS, cognitive deficits, neuropsychiatric disturbances, and hyponatremia. Conclusions Most patients with anti-LGI1 encephalitis are nonparaneoplastic, have low recurrence rates, and have favorable prognostic outcomes. Rapid evaluation, prompt immunotherapy, and long-term follow-up are essential in the care of anti-LGI1 encephalitis patients.
- Published
- 2022
- Full Text
- View/download PDF
9. Extracellular Vesicle-Derived miR-26b-5p is Up-Regulated in the Serum of Patients with Diabetic Retinopathy
- Author
-
Liping Jiang, Bing Wang, Guangwei Jiang, Le Zhang, Yuru Zhang, and Jun Wei
- Subjects
Diabetic Retinopathy ,business.industry ,Organic Chemistry ,Endothelial Cells ,General Medicine ,Diabetic retinopathy ,Extracellular vesicle ,medicine.disease ,Umbilical vein ,Computer Science Applications ,Andrology ,Pathogenesis ,Extracellular Vesicles ,MicroRNAs ,Downregulation and upregulation ,Diabetes mellitus ,Drug Discovery ,microRNA ,Diabetes Mellitus ,Humans ,Medicine ,Endothelial dysfunction ,business ,Biomarkers - Abstract
Background: Diabetic retinopathy (DR) is a severe complication of diabetes; however, the pathogenesis of DR has not been completely clarified, which is mostly dependent on the molecular pathology. To investigate key serum-derived miRNAs associated with DR. Methods: miRNA expression profile arrays of human umbilical vein endothelial cells (HUVECs) treated with glucose were downloaded from the Gene Expression Omnibus (GEO) database (GSE74296). Weighted gene co-expression network analysis (WGCNA) was performed to obtain hub miRNAs, which were verified in HUVECs treated with 40 mM and 5 mM glucose, respectively. Meanwhile, serum samples of patients with DR and healthy controls were collected, and EVs were extracted from the patients’ serum by ultracentrifugation. Hub miRNAs associated with endothelial dysfunction were verified in healthy individuals before and after treatment of patients with DR, by qRT-PCR. Results: These miRNAs were categorized into six modules, among which miR-26b-5p had a strong association with other modules. This miRNA was also one of the hyperglycemia-induced miRNAs related to endothelial dysfunction. miR-26b-5p was upregulated in HUVECs treated with 40 mM glucose and in the serum of patients with DR before and after treatment Furthermore, miR-26b-5p was slightly up-regulated in serum-derived EVs but not in serum without EVs in DM patients. Conclusion: Our results suggest that EVs derived from miR-26b-5p are up-regulated in the serum of patients with DR.
- Published
- 2022
- Full Text
- View/download PDF
10. Efficient Unsupervised Dimension Reduction for Streaming Multiview Data
- Author
-
Haikun Wei, Liping Xie, Dacheng Tao, Weili Guo, and Yuan Yan Tang
- Subjects
Computer science ,business.industry ,Iterative method ,Dimensionality reduction ,010401 analytical chemistry ,02 engineering and technology ,021001 nanoscience & nanotechnology ,Machine learning ,computer.software_genre ,01 natural sciences ,0104 chemical sciences ,Computer Science Applications ,Human-Computer Interaction ,Control and Systems Engineering ,Learning ,Artificial intelligence ,Electrical and Electronic Engineering ,0210 nano-technology ,Representation (mathematics) ,business ,computer ,Algorithms ,Software ,Information Systems - Abstract
Multiview learning has received substantial attention over the past decade due to its powerful capacity in integrating various types of information. Conventional unsupervised multiview dimension reduction (UMDR) methods are usually conducted in an offline manner and may fail in many real-world applications, where data arrive sequentially and the data distribution changes periodically. Moreover, satisfying the requirements of high memory consumption and expensive retraining of the time cost in large-scale scenarios are difficult. To remedy these drawbacks, we propose an online UMDR (OUMDR) framework. OUMDR aims to seek a low-dimensional and informative consensus representation for streaming multiview data. View-specific weights are also learned in this article to reflect the contributions of different views to the final consensus presentation. A specific model called OUMDR-E is developed by introducing the exclusive group LASSO (EG-LASSO) to explore the intraview and interview correlations. Then, we develop an efficient iterative algorithm with limited memory and time cost requirements for optimization, where the convergence of each update is theoretically guaranteed. We evaluate the proposed approach in video-based expression recognition applications. The experimental results demonstrate the superiority of our approach in terms of both effectiveness and efficiency.
- Published
- 2022
- Full Text
- View/download PDF
11. Burden of multiple myeloma in China: an analysis of the Global Burden of Disease, Injuries, and Risk Factors Study 2019
- Author
-
Weiping Liu, T. Gong, Jiangmei Liu, J. Ma, C. Cai, Liping Wang, and Lan Mi
- Subjects
Burden of disease ,Cancer Research ,medicine.medical_specialty ,Oncology ,business.industry ,medicine ,Hematology ,General Medicine ,China ,Intensive care medicine ,business ,medicine.disease ,Multiple myeloma - Published
- 2023
- Full Text
- View/download PDF
12. Imaging Parameters Predict Recurrence After Transient Ischemic Attack or Minor Stroke Stratified by ABCD 2 Score
- Author
-
Jing Jing, Yue Suo, Anxin Wang, Yingting Zuo, Yong Jiang, Liping Liu, Xingquan Zhao, Yilong Wang, Zixiao Li, Hao Li, Xia Meng, Yongjun Wang, Jilai Li, Jian Wu, Mei Zhang, Maolin He, Tao Gong, Quping Ouyang, Guang Huang, Fengchun Yu, Chenlong Wang, Jinli Zhang, Wenqing Wu, Yi Wang, Yaoyu Yu, Meiyun Zhang, Zhongping An, Junyan Liu, Wanying Shi, Baoquan Lu, Lijun Geng, Shujuan Wang, Xu Zhang, Ruifang Liu, Fengli Zhao, Jie Lin, Xinping Liu, Xuebing Sun, Tianyuan Li, Youming Wang, Xinxia He, Weiqiang Yuan, Ronghua Dou, Lihai Liu, Yanling Wang, Junling Zhang, Haisong Du, Yuqing Wei, Cunrui Wang, Limin Wang, Yu’an Zou, Xiaofei Chen, Fengyun Hu, Jinfeng Liu, Lili Zhao, Fanping He, Xingchen Wang, Qingwei Zhao, Xiaohong Li, Jun Zhao, Zhangyong Xia, Hongjin Li, Mingzong Yan, Guiru Zhang, Hui Liang, Yunlin Liu, Jun Xu, Runqing Wang, Yuhui Han, Xianghong Meng, Mingzhen Li, Ting Wang, Xinsheng Han, Hongtian Zhang, Congmin Ma, Wenjun Xue, Chun Wang, Yan Fang, Gexia Liu, Jianfeng Wang, Qiang Ma, Wenxu Zheng, Haitao Chi, Lianbo Gao, Jin Zhou, Huisheng Chen, Juan Feng, Hongbo Xiao, Lijun Xiao, Yi Yang, Guozhong Li, Yulan Zhu, Lihua Wang, Yindong Yang, Xuerong Qiu, Xuhai Gong, Guohua Chen, Xiaoxiang Peng, Qunhui Liu, Shiping Gong, Hongbin Zhou, Haipeng Li, Yong You, Jinsheng Lin, Yun Xu, Lei Sheng, Heqing Zhao, Aixia Zhuang, Kaifu Ke, Qi Fang, Zhengxie Dong, Guiyun Cui, Deqin Geng, Liangqun Rong, Junfeng Shi, Ming Yu, Yu Geng, Benyan Luo, Xueli Cai, Jun Zhou, Yi Wu, Weiguo Tang, Zhimin Wang, Yangmei Chen, Yanjiang Wang, Kangning Chen, Shizheng Wu, Wenguang Bu, Xiaohua Cheng, Zhengqi Lu, An’ding Xu, Jia Yin, Jifu Cai, Yi Guo, Jun Wu, Lvli Li, Li Pan, Yinzhou Wang, Ning Wang, Jianping Niu, Qing Li, Hong Wang, Hongyan Li, Xiaoying Zhang, Liping Zhan, Yongming Chen, Baojun Wang, Li’e Wu, Li Liu, Yanru Zhao, Yingchun Wu, Runxiu Zhu, Yanhui Du, Yongxia Wen, Ye Tian, Songdi Wu, Yongcai Qu, Yuncheng Wu, Jianren Liu, Qiang Dong, Qingke Bai, Yuwu Zhao, Xu Chen, Chaoming He, Lijie Ren, Weiwen Qiu, Shufang Yao, Xuwen Sun, Hainan Zhang, Weirong Li, Ligong Gao, Xianglin Chen, Jianhua Li, Qiuyan Shi, Yan Wang, Mingzhi Zhao, Jinsheng Zeng, Liping Wang, Wei Wang, Feng Qiu, Zhaochen Li, Liang Zhao, Tianbao Chen, Lei Xia, SuYun Yang, Yazhou Han, Liyan Liu, Xinxiao Wu, Beihai Jiang, Lizhong Li, Weidong Lou, Xiaoqian Shen, Ping Zhang, Weiming Lan, Aihu Zheng, Qifu Bai, Lifang Luan, Lin Chen, Liqing Yan, Yanxia Wang, Xuerong Huang, Xiangting Chai, Yanshu Liu, Liangjun You, Hongqin Yang, Dongfang Li, Huijuan Wang, Linying Gui, Aisheng Wu, Jianling Zhang, Dengling Wang, Qinghua Zhang, Yunhong He, Ruiyou Guo, Jijun Teng, and Ping Lou
- Subjects
Advanced and Specialized Nursing ,medicine.medical_specialty ,business.industry ,Stroke recurrence ,Infarction ,Minor stroke ,medicine.disease ,Neuroimaging ,Internal medicine ,Ischemic stroke ,Cardiology ,Medicine ,Transient (computer programming) ,cardiovascular diseases ,Neurology (clinical) ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background and Purpose: Whether imaging parameters would independently predict stroke recurrence in low-risk minor ischemic stroke (MIS) or transient ischemic attack (TIA) according to traditional score system (such as ABCD 2 score, which was termed on the basis of the initials of the five factors: age, blood pressure, clinical features, duration, diabetes) remains unclear. We sought to evaluate the association between imaging parameters and 1-year stroke recurrence in patients with TIA or MIS in different risk stratum stratified by ABCD 2 score. Methods: We included patients with TIA and MIS (National Institutes of Health Stroke Scale score ≤3) with complete baseline vessel and brain imaging data from the Third China National Stroke Registry III. Patients were categorized into different risk groups based on ABCD 2 score (low risk, 0–3; moderate risk, 4–5; and high risk, 6–7). The primary outcome was stroke recurrence within 1 year. Multivariable Cox proportional-hazards regression models were used to assess whether imaging parameters (large artery stenosis, infarction number) were independently associated with stroke recurrence. Results: Of the 7140 patients included, 584 patients experienced stroke recurrence within 1 year. According to the ABCD 2 score, large artery stenosis was associated with higher stroke recurrence in both low-risk (adjusted hazard ratio, 1.746 [95% CI, 1.200–2.540]) and moderate-risk group (adjusted hazard ratio, 1.326 [95% CI, 1.042–1.687]) but not in the high-risk group ( P >0.05). Patients with multiple acute infarctions or single acute infarction had a higher risk of recurrent stroke than those with no infarction in both low- and moderate-risk groups, but not in the high-risk group. Conclusions: Large artery stenosis and infarction number were independent predictors of 1-year stroke recurrence in low-moderate risk but not in high-risk patients with TIA or MIS stratified by ABCD 2 score. This finding emphasizes the importance of early brain and vascular imaging evaluation for risk stratification in patients with TIA or MIS.
- Published
- 2021
- Full Text
- View/download PDF
13. Heme oxygenase-1 induction mitigates burn-associated early acute kidney injury via the TLR4 signaling pathway
- Author
-
Meirong Yu, Quan Fang, Chuangang You, Xingang Wang, Chunmao Han, Songxue Guo, Liping Zhang, and Yong Liu
- Subjects
Inflammation ,Pharmacology ,Kidney ,Critical Care and Intensive Care Medicine ,medicine.disease_cause ,Proinflammatory cytokine ,030207 dermatology & venereal diseases ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,medicine ,Animals ,Humans ,business.industry ,NF-kappa B ,Acute kidney injury ,030208 emergency & critical care medicine ,General Medicine ,Acute Kidney Injury ,medicine.disease ,Rats ,Toll-Like Receptor 4 ,Heme oxygenase ,chemistry ,Heme Oxygenase (Decyclizing) ,Emergency Medicine ,TLR4 ,Surgery ,Tumor necrosis factor alpha ,medicine.symptom ,Burns ,business ,Heme Oxygenase-1 ,Oxidative stress ,Signal Transduction ,Hemin - Abstract
Objectives Early acute kidney injury (AKI) after burn contributes to disastrous prognoses for severely burned patients. Burn-induced renal oxidative stress and secondary proinflammatory mediator release contribute to early AKI development, and Toll-like receptor (TLR) 4 regulates inflammation. Heme oxygenase-1 (HO-1) is a stress-responsive enzyme that plays a vital role in protecting against ischemia-induced organ injury via its antioxidant properties and regulation of inflammation. We investigated the potential effect of HO-1 induction in preventing burn-induced early AKI and its related mechanism. Methods A classic major-burn rat model was established using a 100 °C water bath, and hemin was injected intraperitoneally immediately after the injury to induce HO-1. Histological staining and blood tests were used to assess AKI progression based on structural changes and function. Renal levels of HO-1, oxidative stress, proinflammatory mediators and TLR4-related signals were detected using ELISA, immunostaining, qRT-PCR, and western blotting. The selective TLR4 inhibitor TAK242 and TLR4 inducer LPS were introduced to determine the roles of HO-1 in burn-related renal inflammation and the TLR4 pathway. Results Hemin improved burn-induced renal histological damage and dysfunction, and this beneficial effect was related to reduced renal oxidative stress and the release of proinflammatory mediators, such as tumor necrosis factor-alpha (TNF-α), interleukin (IL)-1β, IL-6 and intracellular adhesion molecule-1 (ICAM-1). Hemin downregulated the expression of TLR4 and the subsequent phosphorylation of IKKα/β, IκBα, and NF-κB p65;. TAK242 exerted an effect similar to but weaker than hemin; and LPS reversed the antiinflammatory effect of hemin and the regulation of TLR4 signals. These results suggested that the TLR4 signaling pathway mediated the HO-1-facilitated regulation of renal inflammation after burn. Conclusion The present study demonstrated that HO-1 induction prevented burn-induced early AKI by targeting renal inflammation, which was mediated via regulation of the TLR4/NF-κB signaling pathway.
- Published
- 2022
- Full Text
- View/download PDF
14. Association of the maternal serum albumin level with fetal growth and fetal growth restriction in term-born singletons: a prospective cohort study
- Author
-
Qin Gao, Li Huang, Yu Zhang, Liping Hao, Xi Chen, Xingwen Hu, Miao Hong, Nianhong Yang, Xuefeng Yang, Ting Xiong, Yuanjue Wu, and Chunrong Zhong
- Subjects
Adult ,China ,medicine.medical_specialty ,Percentile ,Maternal Health ,Birth weight ,Serum Albumin, Human ,Risk Assessment ,Fetal Development ,Serum albumin level ,Risk Factors ,Fetal growth ,medicine ,Birth Weight ,Humans ,Prospective Studies ,Prospective cohort study ,Pregnancy ,Fetal Growth Retardation ,Obstetrics ,business.industry ,Infant, Newborn ,Obstetrics and Gynecology ,medicine.disease ,Up-Regulation ,Reproductive Medicine ,Liver function ,business ,Biomarkers ,Cohort study - Abstract
Objective To investigate the association of the maternal serum albumin (MAlb) level with fetal growth and fetal growth restriction (FGR) risk in term-born singletons. Design Prospective cohort study. Setting Four hospital maternity units of the Tongji Maternal and Child Health Cohort study initiated from September 2013 to April 2016 at Wuhan City, in central China. Patient(s) A total of 3,065 mother–offspring pairs. Intervention(s) None. Main Outcome Measure(s) Fetal growth was evaluated by birth weight (BW) and birth length. Fetal growth restriction was defined as BW below the 10th percentile. Result(s) All MAlb levels were within the upper limit of normal. After adjustment for liver function parameters, inflammatory indicators, and others, a reverse U-shaped relationship between MAlb and fetal growth was observed. Specifically, BW increased significantly with an increasing MAlb level when the MAlb level was 36.1 g/L (per g/L: β = −15.1; 95% CI, −21.2, −8.9). There was a similar association between MAlb and birth length. Furthermore, the adjusted odd ratios of FGR across increasing tertiles of the MAlb levels were 1.0 (reference), 1.1 (0.7, 1.8), and 1.7 (1.0, 2.6). Conclusion(s) There was a reverse U-shaped association between MAlb and fetal growth. A higher MAlb level was associated with an increased risk of FGR. Clinical Trial Registration Number NCT03099837.
- Published
- 2022
- Full Text
- View/download PDF
15. Enhanced Photoelectric Properties of Multilayer Graphene Mg2Si/Si Heterojunction Photodetector
- Author
-
Shentong Ji, Hong Yu, Zhangjie Mo, Liping Sun, Quan Xie, and Rui Deng
- Subjects
Materials science ,business.industry ,Graphene ,Photodetector ,Heterojunction ,Atomic and Molecular Physics, and Optics ,law.invention ,Responsivity ,law ,Optoelectronics ,Breakdown voltage ,Quantum efficiency ,Electrical and Electronic Engineering ,business ,Noise-equivalent power ,Dark current - Abstract
In this paper, we establish the structure model of multilayer Graphene (MLG)/Mg2Si/Si heterojunction photodetector (PD) based on the Technology CAD (TCAD). We further investigate the effect of Graphene layers on the photoelectric properties of MLG/Mg2Si/Si heterojunction PD. The simulation results indicate that compared with Mg2Si/Si PD, the photoelectric properties of MLG/Mg2Si/Si heterojunction PD are enhanced. The responsivity is increased from 0.51 A/W to 0.84 A/W, the external quantum efficiency (EQE) increased from 70.68% to 107.29%, and the noise equivalent power (NEP) reduced from 7.071011 WHz1/2 to 1.591011 WHz1/2. It is further shown that detectivity (D*) is increased from 1.41010 Jones to 6.31010 Jones, and the on/off ratio is increased from 141.45 to 629. After adding Graphene layers, the maximum improvement rates of the responsivity, EQE, NEP, D*, and on/off ratio of heterojunction PDs improved by 65%, 52%, 77.5%, 350%, and 345%, respectively. Moreover, it is seen that the energy band of MLG/Mg2Si/Si heterojunction PDs is shifted to the valence band, the reverse breakdown voltage and dark current are decreased. A strong electric field is formed at the interface between MLG and Mg2Si, which is beneficial to the separation of photogenic carriers.
- Published
- 2022
- Full Text
- View/download PDF
16. Surveillance of Liver Function in Uveitis with or without Chronic HBV Infection
- Author
-
Xiaojie Feng, Liping Du, Lingyu Dai, Peizeng Yang, Fuzhen Li, Guannan Su, Weiting Liao, Aize Kijlstra, Zhenyu Zhong, RS: MHeNs - R3 - Neuroscience, and MUMC+: MA Oogheelkunde (9)
- Subjects
Liver damage ,medicine.medical_specialty ,Hepatitis B virus ,HEPATITIS-B ,GUIDELINES ,Gastroenterology ,Systemic therapy ,THERAPY ,DISEASE ,Serology ,Uveitis ,Cellular and Molecular Neuroscience ,Prednisone ,Internal medicine ,B-VIRUS REACTIVATION ,medicine ,Clinical endpoint ,Humans ,Corticosteroids ,DRUGS ,Hepatitis B Antibodies ,Retrospective Studies ,business.industry ,Incidence (epidemiology) ,Panuveitis ,General Medicine ,medicine.disease ,Hepatitis B ,Sensory Systems ,Ophthalmology ,Liver function ,business ,medicine.drug - Abstract
Introduction: Immunosuppressive therapy for uveitis may cause liver damage. Methods: To investigate incidence of liver damage during uveitis treatment, we compared serological Hepatitis B core antibody (HBcAb) status with risk of liver dysfunction in all participants (n = 992), in anterior uveitis (AU) (n = 489), and combined of intermediate, posterior, or panuveitis (IPPU) patients (n = 503). The primary endpoint was incidence of elevated serum alanine aminotransferase level above 2-fold upper limits of normal within 6 months. Results: The incidence rate of primary endpoint for HBcAb-negative and HBcAb-positive patients was 65 and 212 per 1,000 person years, respectively. The absolute rate difference was 147 (95% confidence interval [CI], 80–213) per 1,000 person years. HBcAb positivity was associated with a higher risk for primary endpoint in all participants (adjusted hazard ratio [aHR], 3.53; 95% CI, 1.79–6.99; p value = 2.8 × 10−4) and in IPPU (aHR, 3.80; 95% CI, 1.61–9.01; p value = 0.002). No significant association with primary endpoint was observed for HBcAb positivity in AU (aHR, 3.21; 95% CI, 0.94–10.95; p value = 0.063). AU was mainly treated with topical eye drops (74.0%), whereas IPPU cases received systemic therapy including prednisone (94.0%), cyclosporine (80.9%), or other additionally combined immunomodulatory agents (14.9%). Conclusion: Noninfectious uveitis cases with HBcAb positivity have an increased risk of liver damage. This association was predominantly driven by IPPU but was not significant in AU, suggesting that the association is mediated by systemic therapy.
- Published
- 2022
- Full Text
- View/download PDF
17. Vps34 Inhibits Hepatocellular Carcinoma Invasion by Regulating Endosome-Lysosome Trafficking via Rab7-RILP and Rab11
- Author
-
Xing Mao, Liping Zou, Zhigang Zhang, Jiaoyu Shi, Chenyang Qi, Yuan Hu, Suxia Wang, and Huijuan Wu
- Subjects
0301 basic medicine ,Cancer Research ,Carcinoma, Hepatocellular ,Vesicular transportation ,Endosome ,Cell ,Mice, Nude ,Endocytic recycling ,Endocytosis ,Mice ,03 medical and health sciences ,0302 clinical medicine ,In vivo ,Cell surface receptor ,Cell Line, Tumor ,Rab7 ,Lysosome ,Gastrointestinal Cancer ,medicine ,Animals ,Humans ,Neoplasm Invasiveness ,neoplasms ,Adaptor Proteins, Signal Transducing ,business.industry ,Liver Neoplasms ,fungi ,rab7 GTP-Binding Proteins ,Class III Phosphatidylinositol 3-Kinases ,digestive system diseases ,In vitro ,Cell invasion ,Juxtanuclear lysosome aggregation ,030104 developmental biology ,medicine.anatomical_structure ,Oncology ,Endosome-lysosome system ,Rab11 ,030220 oncology & carcinogenesis ,Cancer research ,Female ,Original Article ,Recycling endosome ,RILP ,business ,Lysosomal trafficking - Abstract
Purpose The role of vacuolar protein sorting 34 (Vps34), an indispensable protein required for cell vesicular trafficking, in the biological behavior of hepatocellular carcinoma (HCC) has yet to be studied.Materials and Methods In the present study, the expression of Vps34 in HCC and the effect of Vps34 on HCC cell invasion was detected both in vivo and in vitro. Furthermore, by modulating the RILP and Rab11, which regulate juxtanuclear lysosome aggregation and recycling endosome respectively, the underlying mechanism was investigated.Results Vps34 was significantly decreased in HCC and negatively correlated with the HCC invasiveness both in vivo and in vitro. Moreover, Vps34 could promote lysosomal juxtanuclear accumulation, reduce the invasive ability of HCC cells via the Rab7-RILP pathway. In addition, the deficiency of Vps34 in HCC cells affected the endosome-lysosome system, resulting in enhanced Rab11 mediated endocytic recycling of cell surface receptor and increased invasion of HCC cells.Conclusion Our study reveals that Vps34 acts as an invasion suppressor in HCC cells, and more importantly, the endosome-lysosome trafficking regulated by Vps34 has the potential to become a target pathway in HCC treatment.
- Published
- 2022
- Full Text
- View/download PDF
18. Effects of attachment type and number of dental implants supporting mandibular overdenture on peri-implant health: A systematic review and network meta-analysis
- Author
-
Linhu Ge, Xueqi Guo, Taghrid Aldhohrah, Liping Wang, Ye Bi, Yucheng Su, Zhe Yang, and Mubarak Ahmed Mashrah
- Subjects
Dental Implants ,business.industry ,Network Meta-Analysis ,Peri ,MEDLINE ,Dentistry ,Bayes Theorem ,Mandible ,Cochrane Library ,Denture, Overlay ,bacterial infections and mycoses ,Weighted mean difference ,Meta-analysis ,Credible interval ,Humans ,Jaw, Edentulous ,Medicine ,Dentistry (miscellaneous) ,Dental Prosthesis, Implant-Supported ,Implant ,Oral Surgery ,business ,Survival rate - Abstract
PURPOSE To evaluate the effect of overdenture (OD) attachment type and the number of implants supporting mandibular ODs on peri-implant health. STUDY SELECTION From inception to October 2020, electronic databases (Medline/PubMed, Embase, Cochrane Library, and Scopus) were systematically searched. The outcomes of interest were marginal bone loss (MBL), pocket probing depth (PPD), plaque index, bleeding index, and implant survival rate. Bayesian network meta-analysis was performed using the GeMTC package supported by R. The weighted mean difference and 95% credible interval were estimated. RESULTS Twenty-eight studies with a total of 1166 participants who received 2666 dental implants were included. Except for 4 bar and 4 telescopic, which showed a statistically lower MBL than the 2 locator, all other interventions showed insignificant differences in MBL (P > 0.05). The difference in periodontal probing depth was not statistically significant when comparing the different groups. The pooled implant survival rates of the different interventions ranged from 88.9% to 100%. The rank probability test showed that 4 bar and 4 telescopic had the lowest MBL, 2 magnet and 2 bar had the highest PI, whereas 4 locator showed the least PPD. CONCLUSIONS Except for 4 implants+bar, or telescopic, and 4 locator that, respectively, showed less MBL and PPD compared to some interventions, it seemed that different attachment types and number of implants supporting mandibular ODs have no clear superiority over the other in terms of peri-implant health outcomes.
- Published
- 2022
- Full Text
- View/download PDF
19. Establishment and validation of psoriasis evaluation models
- Author
-
Liping Luo, Qinghai Zeng, Li Lei, Ying Zhou, Yibo Hu, Jinhua Huang, Haoran Guo, Jing Chen, and Ling Jiang
- Subjects
medicine.medical_specialty ,business.industry ,Psoriasis ,medicine ,business ,medicine.disease ,Dermatology - Published
- 2022
- Full Text
- View/download PDF
20. Assessment of Reversibility in Pulmonary Hypertension Related to Congenital Heart Disease by Using Biomarkers and Clinical Features
- Author
-
Liping Wang, Zhuoming Xu, Xi Chen, Jiaqi Liu, Mingjie Zhang, and Yachang Pang
- Subjects
medicine.medical_specialty ,Heart disease ,business.industry ,General Medicine ,medicine.disease ,Pulmonary hypertension ,Internal medicine ,Pediatrics, Perinatology and Child Health ,medicine ,Cardiology ,Radiology, Nuclear Medicine and imaging ,Surgery ,Cardiology and Cardiovascular Medicine ,business - Published
- 2022
- Full Text
- View/download PDF
21. Sequential Fusion for Multirate Multisensor Systems With Heavy-Tailed Noises and Unreliable Measurements
- Author
-
Chenying Di, Q. M. Jonathan Wu, Yuanqing Xia, and Liping Yan
- Subjects
Human-Computer Interaction ,Fusion ,Control and Systems Engineering ,Computer science ,business.industry ,Pattern recognition ,Artificial intelligence ,Electrical and Electronic Engineering ,business ,Software ,Computer Science Applications - Published
- 2022
- Full Text
- View/download PDF
22. ARFace: Attention-Aware and Regularization for Face Recognition With Reinforcement Learning
- Author
-
Liping Zhang, Jinchao Chen, Weiwei Cai, Xin Ning, Xiaoli Dong, Lina Yu, Linjun Sun, and Chen Wang
- Subjects
Discriminative model ,Computer science ,business.industry ,Face (geometry) ,Feature (machine learning) ,Reinforcement learning ,Embedding ,Pattern recognition ,Artificial intelligence ,business ,Facial recognition system ,Convolutional neural network ,Regularization (mathematics) - Abstract
Different face regions have different contributions to recognition. Especially in the wild environment, the difference of contributions will be further amplified due to a lot of interference. Based on this, this paper proposes an attention-aware face recognition method based on a deep convolutional neural network and reinforcement learning. The proposed method composes of an Attention-Net and a Feature-net. The Attention-Net is used to select patches in the input face image according to the facial landmarks and trained with reinforcement learning to maximize the recognition accuracy. The Feature-net is used for extracting discriminative embedding features. In addition, a regularization method has also been introduced. The mask of the input layer is also applied to the intermediate feature maps, which is an approximation to train a series of models for different face patches and provide a combined model. Our method achieves satisfactory recognition performance on its application to the public prevailing face verification database.
- Published
- 2022
- Full Text
- View/download PDF
23. Solution-processed vanadium oxides as a hole-transport layer for Sb2Se3 thin-film solar cells
- Author
-
Dian Li, Yufeng Zheng, Lin Li, S.N. Vijayaraghavan, Feng Yan, Harigovind G. Menon, Liping Guo, Mark Ming-Cheng Cheng, Subhadra Gupta, Jacob Wall, Xiaomeng Duan, and Al Amin
- Subjects
Materials science ,Renewable Energy, Sustainability and the Environment ,business.industry ,Photovoltaic system ,Oxide ,chemistry.chemical_element ,Vanadium ,law.invention ,chemistry.chemical_compound ,chemistry ,Antimony ,law ,Selenide ,Solar cell ,Optoelectronics ,General Materials Science ,Sublimation (phase transition) ,business ,Layer (electronics) - Abstract
Antimony selenide (Sb2Se3) is a promising light absorber material for solar cells because of its superior photovoltaic properties. However, the current performance of the Sb2Se3 solar cell is much lower than its theoretical value (∼32%) due to its low open-circuit voltage (VOC). In this paper, we have demonstrated inorganic vanadium oxides (VOx) as a hole transport layer (HTL) for Sb2Se3 solar cells to enhance efficiency through the VOC improvement. Here, a solution-processed VOx through the decomposition of the triisopropoxyvanadium (V) oxide is deposited on the Sb2Se3 absorber layer prepared by close-spaced sublimation (CSS). With VOx HTL, the built-in voltage (Vbi) is significantly increased, leading to improved VOC for the Sb2Se3 solar cell devices. As a result, the efficiency of the device increases from an average efficiency of 5.5% to 6.3% with the VOx.
- Published
- 2022
- Full Text
- View/download PDF
24. NLRNet: An Efficient Nonlocal Attention ResNet for Pansharpening
- Author
-
Chen Hao, Weisheng Li, Liping Zhang, and Dajiang Lei
- Subjects
Visual perception ,Pixel ,Computer science ,business.industry ,Initialization ,Pattern recognition ,Residual ,Signal ,Convolutional neural network ,Convolution ,Zero (linguistics) ,General Earth and Planetary Sciences ,Artificial intelligence ,Electrical and Electronic Engineering ,business - Abstract
Remote sensing images often contain many similar components, such as buildings, roads, and water surfaces, which have similar spectra and spatial structures. Although convolutional neural networks (CNNs) based on residual learning can provide excellent performance in pansharpening, the existing methods do not make full use of intrinsically similar information in images. Moreover, since the convolution operation is focused on the local region, even in a deep network, position-independent global information is difficult to obtain. In this article, an efficient nonlocal attention residual network (NLRNet) is proposed to capture the similar contextual dependencies of all pixels. Specifically, to reduce the difficulty of network training caused by the original nonlocal attention, we propose an efficient nonlocal attention (ENLA) mechanism and employ residual with zero initialization (ReZero) technology to make the signal easy to spread through the network. Furthermore, a spectral aggregation module (SpecAM) is proposed to generate fused images and adjust the corresponding spectral information. The experimental results for the QuickBird and WorldView3 data sets show that the proposed method is competitive with other advanced methods based on quality assessment and visual perception.
- Published
- 2022
- Full Text
- View/download PDF
25. The Involvement of Glial Cell-Derived Neurotrophic Factor in Inflammatory Bowel Disease
- Author
-
Liping Gao, Tiyun Han, Huiling Chen, and Dekui Zhang
- Subjects
biology ,urogenital system ,Colorectal cancer ,business.industry ,animal diseases ,Immunology ,Cell Biology ,Inflammatory Bowel Diseases ,medicine.disease ,Inflammatory bowel disease ,Pathogenesis ,Paracrine signalling ,Immune system ,nervous system ,Neurotrophic factors ,Virology ,Glial cell line-derived neurotrophic factor ,biology.protein ,medicine ,Cancer research ,Humans ,Enteric nervous system ,Glial Cell Line-Derived Neurotrophic Factor ,Prospective Studies ,business - Abstract
Inflammatory bowel diseases (IBD) are chronic inflammatory gastrointestinal diseases characterized by dysregulation of the intestinal epithelial barrier (IEB) and intermittent relapses. Recent data show that the glial cell line-derived neurotrophic factor (GDNF) promotes IEB function and wound healing. Apart from protective effects of GDNF on enteric nervous system and IEB, an immunomodulatory role has been assumed. However, it is inconsistent whether GDNF levels are increased or decreased in the inflamed colon of patients with IBD. Furthermore, GDNF is 1 of 3 protein markers associated with relapse in a prospective cohort study in IBD patients with clinically and endoscopically quiescent disease. Additionally, not only enteric glial cells (EGCs), but also intestinal smooth muscle cells and enterocytes synthesize GDNF in significant amounts; in addition, its receptors are expressed in intestinal neurons, EGCs, immune cells and epithelial cells, which points to a potential auto- or paracrine signaling loop between some of these cells. Whether GDNF is involved in IBD-associated fibrosis and colitis-associated colorectal cancer remains to be confirmed. In this review we aim to summarize and discuss the current knowledge on the effects of GDNF and its potential role in the contribution to the pathogenesis of IBD.
- Published
- 2022
- Full Text
- View/download PDF
26. Molecular signaling in temporomandibular joint osteoarthritis
- Author
-
Di Chen, Dan Yi, Ke Lu, Huan Yu, Liping Tong, and Feng Ma
- Subjects
Indian hedgehog ,TMJ disorders ,Osteoarthritis ,Diseases of the musculoskeletal system ,Fibroblast growth factor ,Bioinformatics ,Mechanical loading ,Temporomandibular joint ,stomatognathic system ,medicine ,Orthopedics and Sports Medicine ,Molecular signaling ,biology ,business.industry ,Wnt signaling pathway ,medicine.disease ,biology.organism_classification ,Review article ,stomatognathic diseases ,medicine.anatomical_structure ,RC925-935 ,Joint pain ,medicine.symptom ,Cartilage degradation ,business - Abstract
Objective Temporomandibular joint (TMJ) osteoarthritis (OA) is a type of TMJ disorders with clinical symptoms of pain, movement limitation, cartilage degeneration and joint dysfunction. This review article is aiming to summarize recent findings on signaling pathways involved in TMJ OA development and progression. Methods Most recent findings in TMJ OA studies have been reviewed and cited. Results TMJ OA is caused by inflammation, abnormal mechanical loading and genetic abnormalities. The molecular mechanisms related to TMJ OA have been determined using different genetic mouse models. Recent studies demonstrated that several signaling pathways are involved in TMJ OA pathology, including Wnt/β-catenin, TGF-β and BMP, Indian Hedgehog, FGF, NF-κB, and Notch pathways, which are summarized in this review article. Alterations of these signaling pathways lead to the pathological changes in TMJ tissues, affecting cartilage matrix degradation, catabolic metabolism and chondrocyte apoptosis. Conclusion Multiple signaling pathways were involved in the pathological process of TMJ OA. New therapeutic strategies, such as stem cell application, gene editing and other techniques may be utilized for TMJ OA treatment. The translational potential of this article TMJ OA is a most important subtype of TMJ disorders and may lead to substantial joint pain, dysfunction, dental malocclusion, and reduced health-related quality of life. This review article summarized current findings of signaling pathways involved in TMJ OA, including Wnt/β-catenin, TGF-β and BMP, Indian Hedgehog, FGF, NF-κB, and Notch pathways, to better understand the pathological mechanisms of TMJ OA and define the molecular targets for TMJ OA treatment.
- Published
- 2022
27. A Joint Bayesian Framework Based on Partial Least Squares Discriminant Analysis for Finger Vein Recognition
- Author
-
Chuantong Cheng, Weiwei Cai, Liping Zhang, Ning Xin, Li Weijun, Linjun Sun, and Jianming Zhang
- Subjects
business.industry ,Computer science ,Partial least squares regression ,Pattern recognition ,Bayesian framework ,Artificial intelligence ,Electrical and Electronic Engineering ,Linear discriminant analysis ,business ,Instrumentation ,Joint (geology) ,Finger vein recognition - Published
- 2022
- Full Text
- View/download PDF
28. Recent developments of Co3O4-based materials as catalysts for the oxygen evolution reaction
- Author
-
Fan Quan, Liping Hao, Zhenyu Hu, and Rui Guo
- Subjects
Materials science ,Electrolysis of water ,Hydrogen ,business.industry ,Fossil fuel ,Oxide ,Oxygen evolution ,chemistry.chemical_element ,Nanotechnology ,Catalysis ,chemistry.chemical_compound ,chemistry ,Water splitting ,business ,Efficient energy use - Abstract
The demand for the development of clean and efficient energy is becoming more and more pressing due to depleting fossil fuels and environmental concerns. Hydrogen is a high energy density with sanitary combustion products. However, the oxygen evolution reaction (OER) becomes the critical process in water decomposition reaction due to the slow kinetics of OER limits the electrochemical water splitting. In recent years, among many electrocatalysts, transition metal oxides have received extensive attention due to their inexpensive, remarkable activity and stability. Among them, Co3O4-based materials have become one of the best candidates for electrocatalysts dedicated to the oxidation of water to oxygen due to their excellent catalytic performance. The recent progress of Co3O4-based materials in the OER is summarized in detail, involving pure Co3O4, doped Co3O4 and Co3O4-based compound composites. Moreover, this review discusses the influence of strategies on the performance of electrocatalysts, such as morphological engineering, interface engineering, synthesis method and doping. At the end of this review, the obstacles and feasible opinions of Co3O4-based materials in OER are put forward, and their future research prospects are also discussed. This review can provide a valuable reference to the research and exploitation of related transition metal oxide catalysts.
- Published
- 2022
- Full Text
- View/download PDF
29. Safety and efficacy of Compound Huangdai Tablets combined with all-trans retinoic acid for treatment of acute promyelocytic leukemia: Clinical evidence and potential mechanisms
- Author
-
Wenjun Zou, Qiao-zhi Yin, Tao Wang, Liping Qu, Yan Xiong, and Qianqian Huang
- Subjects
Pharmacology ,Acute promyelocytic leukemia ,Oncology ,medicine.medical_specialty ,business.industry ,Retinoic acid ,All trans ,Cochrane Library ,medicine.disease ,chemistry.chemical_compound ,Complementary and alternative medicine ,chemistry ,Maintenance therapy ,immune system diseases ,Clinical evidence ,Apoptosis ,Internal medicine ,medicine ,Pharmacology (medical) ,Arsenic trioxide ,business ,neoplasms - Abstract
Objective To evaluate the safety and efficacy of Compound Huangdai Tablets (Realgar-Indigo Naturalis formula, RIF) combined with all-trans retinoic acid (ATRA) to treat acute promyelocytic leukemia (APL). Methods This study was registered in PROSPERO (CRD42018108118). The relevant literatures on RIF treatment of APL were systematically searched in the following databases: China National Knowledge Infrastructure, Wanfang, VIP Medical Information System, Chinese Biomedical Database, EMBASE, Cochrane Library, and PubMed. The quality of the included studies was evaluated and Review Manager 5.3 software and Stata 13.0 software were used to perform the Meta-analysis. In addition, this study used the method of network pharmacology to conduct a preliminary exploration of the mechanism of RIF on APL. Results The study included 12 studies involving 775 APL patients. The Meta-analysis showed that there was no significant difference (P > 0.05) between the RIF group and the arsenic trioxide (ATO) group for primary outcomes, secondary outcomes apart from liver dysfunction. The incidence of liver dysfunction (P = 0.006) in the RIF group were significantly lower than those in the ATO group. In addition, the cost of maintenance therapy in the RIF group was significantly lower (P < 0.05) than the ATO group. Besides, the active ingredients in RIF mainly act on targets proteins such as ACHE, NCOA2, RXRA, and then play a role in the treatment of APL through regulating multiple molecular mechanisms, such as TP53 regulates transcription of cell cycle genes, nuclear receptor transcription pathway. Conclusion There was no significant difference in efficacy of oral RIF combined with ATRA compared with intravenous ATO combined with ATRA for the treatment of APL. The oral RIF exposed patients to less risk, offered more convenience and had lower prices. RIF can treat APL by multi-target and multi-pathway interventions that inducing apoptosis of APL cells and inhibiting the proliferation of APL cells, and so on. Therefore, oral RIF in the treatment of APL is worthy of further research and development.
- Published
- 2022
- Full Text
- View/download PDF
30. Computer generation of detailed reaction networks in hydrocracking of Fischer-Tropsch wax
- Author
-
Liping Zhou, Yongwang Li, Jingjing Wang, Kunpeng Song, Hongwei Xiang, Yong Yang, and Wei Zhao
- Subjects
Wax ,Environmental Engineering ,Materials science ,Basis (linear algebra) ,business.industry ,General Chemical Engineering ,Fischer–Tropsch process ,General Chemistry ,Biochemistry ,Matrix (mathematics) ,Transformation matrix ,visual_art ,visual_art.visual_art_medium ,Adjacency list ,Process engineering ,business ,Computer memory ,Eigenvalues and eigenvectors - Abstract
Fischer-Tropsch synthesis (FTS) wax is a mixture of linear hydrocarbons with carbon number from C7 to C70+. Converting FTS wax into high-quality diesel (no sulfur and nitrogen contents) by hydrocracking technology is attractive in economy and practicability. Kinetic study of the hydrocracking of FTS wax in elementary step level is very challenging because of the huge amounts of reactions and species involved. Generation of reaction networks for hydrocracking of FTS wax in which the chain length goes up to C70 is described on the basis of Boolean adjacency matrixes. Each of the species (including paraffins, olefins and carbenium ions) involved in the elementary steps is represented digitally by using a (N+3)×N matrix, in which a group of standardized numbering rules are designed to guarantee the unique identity of the species. Subsequently, the elementary steps are expressed by computer-aided matrix transformations in terms of proposed reaction rules. Dynamic memory allocation is used in species storage and a characteristic vector with nine elements is designed to store the key information of a (N+3)×N matrix, which obviously reduces computer memory consumption and improves computing efficiency. The detailed reaction networks of FTS wax hydrocracking can be generated smoothly and accurately by the current method. The work is the basis of advanced elementary-step-level kinetic modeling.
- Published
- 2022
- Full Text
- View/download PDF
31. Multibranch Feature Extraction and Feature Multiplexing Network for Pansharpening
- Author
-
Dajiang Lei, Yihang Huang, Liping Zhang, and Weisheng Li
- Subjects
Network architecture ,Artificial neural network ,business.industry ,Computer science ,Feature extraction ,Pattern recognition ,Sharpening ,Multiplexing ,Field (computer science) ,Panchromatic film ,Feature (computer vision) ,General Earth and Planetary Sciences ,Artificial intelligence ,Electrical and Electronic Engineering ,business - Abstract
With the continuous development of deep neural networks in the visual field, their application to panchromatic sharpening has received increasing attention from researchers; however, the existing panchromatic sharpening methods generally lack the ability to combine knowledge of the panchromatic sharpening field for feature extraction with neural networks, which have certain limitations in feature extraction and the discovery of new features. This article proposes a simple, modular, multibranched feature extraction and reuses network architecture designed not only to support feature reuse but to learn well-expressed new features for use in panchromatic sharpening approaches. In addition, we fused field knowledge of panchromatic sharpening to extract spatial structure information of panchromatic maps through gradient calculators and design structural and spectral compensation to fully extract and preserve the spatial structural and spectral information of images. We conducted experiments on the QuickBird and WorldView-3 satellite data sets, and the experimental results reveal that our proposed method has advantages over the best methods currently available, achieving excellent results not only on objective evaluation metrics, such as full-reference and no-reference metrics, but also on subjective visual evaluation.
- Published
- 2022
- Full Text
- View/download PDF
32. Cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy
- Author
-
Xinghan Wu, Xiaoming Cui, Xiuwen Guan, Weifen Zhang, Liping Zhao, Mingxia Jiang, Jinlong Ma, and Yuhan Zhang
- Subjects
Medicine (General) ,Science (General) ,medicine.medical_treatment ,T cell ,Programmed Cell Death 1 Receptor ,Protamine ,Cancer immunotherapy ,Cancer Vaccines ,Mice ,Q1-390 ,R5-920 ,Antigen ,Neoplasms ,CpG ,PD-1 ,Animals ,Medicine ,ComputingMethodologies_COMPUTERGRAPHICS ,Multidisciplinary ,biology ,business.industry ,Immunotherapy ,Blockade ,Mice, Inbred C57BL ,Ovalbumin ,Nanovaccine ,medicine.anatomical_structure ,OVA ,biology.protein ,Cancer research ,Nanoparticles ,Antibody ,business ,Adjuvant - Abstract
Graphical abstract, Highlights • Facile antigen/adjuvant co-loaded nanovaccine made by convenient green preparation. • The immunological activity of the antigen and adjuvant was maximally preserved. • The minimalist nanovaccine had excellent stability and antitumor immune activation. • Nanovaccine combined with PD-1 antibody synergistically enhanced therapy outcome. • Good practicability for expanding clinical translation and personalized therapy., Introduction Tumor vaccine has been a research boom for cancer immunotherapy, while its therapeutic outcome is severely depressed by the vulnerable in vivo delivery efficiency. Moreover, tumor immune escape is also another intractable issue, which has badly whittled down the therapeutic efficiency. Objectives Our study aims to solve the above dilemmas by cooperating minimalist nanovaccine with PD-1 blockade for effective and feasible cancer immunotherapy. Methods The minimalist antigen and adjuvant co-delivery nanovaccine was developed by employing natural polycationic protamine (PRT) to carry the electronegative ovalbumin (OVA) antigen and unmethylated Cytosine-phosphorothioate-Guanine (CpG) adjuvant via convenient chemical bench-free “green” preparation without chemical-synthesis and no organic solvent was required, which could preserve the immunological activities of the antigens and adjuvants. On that basis, PD-1 antibody (aPD-1) was utilized to block the tumor immune escape and cooperate with the nanovaccine by maintaining the tumoricidal-activity of the vaccine-induced T cells. Results Benefited from the polycationic PRT, the facile PRT/CpG/OVA nanovaccine displayed satisfactory delivery performance, involving enhanced cellular uptake in dendritic cells (DCs), realizable endosomal escape and promoted stimulation for DCs’ maturation. These features would be helpful for the antitumor immunotherapeutic efficiency of the nanovaccine. Furthermore, the cooperation of the nanovaccine with aPD-1 synergistically improved the immunotherapy outcome, profiting by the cooperation of the “T cell induction” competency of the nanovaccine and the “T cell maintenance” function of the aPD-1. Conclusion This study will provide new concepts for the design and construction of facile nanovaccines, and contribute valuable scientific basis for cancer immunotherapy.
- Published
- 2022
33. Regional differentiation in the ecological effects of land cover change in China
- Author
-
Yanxu Liu, Donglin Fan, Hui Wang, Yijia Wang, Ying Yao, and Liping Cai
- Subjects
Geography ,business.industry ,Agroforestry ,Land degradation ,Soil Science ,Environmental Chemistry ,Land development ,Land cover ,Development ,business ,China ,General Environmental Science - Published
- 2021
- Full Text
- View/download PDF
34. Non‐synonymous alterations in AKR7A3 and ABCA6 correlate with bleeding in aged patients treated with rivaroxaban
- Author
-
Mingliang Gu, Ming Zhao, Xizi Wang, Rongrong Li, Conghui Tian, Qiang Zhang, Xiaodong Jia, Qianqian Zhang, and Liping Yang
- Subjects
Hemorrhage ,Pharmacology ,General Biochemistry, Genetics and Molecular Biology ,Thrombin ,Rivaroxaban ,In vivo ,Genotype ,medicine ,Humans ,General Pharmacology, Toxicology and Pharmaceutics ,Aged ,Venous Thrombosis ,business.industry ,General Neuroscience ,Anticoagulants ,General Medicine ,medicine.disease ,Venous thrombosis ,Coagulation ,ATP-Binding Cassette Transporters ,Signal transduction ,business ,Adverse drug reaction ,Factor Xa Inhibitors ,medicine.drug - Abstract
Rivaroxaban is an oral anticoagulant that inhibits thrombin and blocks coagulation cascade through directly inactivating factors Xa. Despite rivaroxaban is widely used for prevention and treatment of venous thrombosis, and its common adverse reactions have been reported, including abnormal coagulation, mucosal hemorrhage, hematuria, and intracranial hemorrhage. To explore potential drivers of individual differences in adverse reactions induced by rivaroxaban, we performed whole-exome sequencing and found that AKR7A3 rs1738023/rs1738025 and ABCA6 rs7212506 are susceptible sites for rivaroxaban-related bleeding in aged patients treated with rivaroxaban. Gene functional annotation and signaling pathway enrichment indicated that homozygous mutations in AKR7A3 and ABCA6 might alter normal rivaroxaban transport and metabolism, and lead to continuous accumulation of activated drugs and toxic substances in vivo. Our results suggested that interindividual differences in bleeding events induced by rivaroxaban may be potentially driven by genetic alterations related to abnormal metabolism and transport of rivaroxaban.
- Published
- 2021
- Full Text
- View/download PDF
35. Rho kinase inhibition ameliorates vascular remodeling and blood pressure elevations in a rat model of apatinib-induced hypertension
- Author
-
Caie Li, Jing Yu, Liping Ma, Xuejiao Shao, Lu Guo, Wenjuan Wang, Qiongying Wang, and Jian-Shu Chen
- Subjects
RHOA ,Pyridines ,Physiology ,Blood Pressure ,Vascular Remodeling ,Pharmacology ,Rats, Inbred WKY ,chemistry.chemical_compound ,Downregulation and upregulation ,Internal Medicine ,Animals ,Humans ,Medicine ,Apatinib ,Adverse effect ,Rho-associated protein kinase ,rho-Associated Kinases ,biology ,business.industry ,Rats ,Blood pressure ,chemistry ,Hypertension ,biology.protein ,Female ,Signal transduction ,rhoA GTP-Binding Protein ,Cardiology and Cardiovascular Medicine ,business ,Tyrosine kinase - Abstract
OBJECTIVES Hypertension is one of the major adverse effects of tyrosine kinase inhibitors (TKIs) targeting vascular endothelial growth factors. However, the mechanism underlying TKIs-induced hypertension remains unclear. Here, we explored the role of the RhoA/Rho kinase (ROCK) signaling pathway in elevation of blood pressure (BP) induced by apatinib, a selective TKI approved in China for treatment of advanced or metastatic gastric cancer. A nonspecific ROCK inhibitor, Y27632, was then combined with apatinib and its efficacy in alleviating apatinib-induced hypertension was evaluated. METHODS Normotensive female Wistar-Kyoto rats were exposed to two different doses of apatinib, or apatinib combined with Y27632, or vehicle for 2 weeks. BP was monitored by a tail-cuff plethysmography system. The mRNA levels and protein expression in the RhoA/ROCK pathway were determined, and vascular remodeling assessed. RESULTS Administration of either a high or low dose of apatinib was associated with a rapid rise in BP, reaching a plateau after 12 days. Apatinib treatment mediated upregulation of RhoA and ROCK II in the mid-aorta, more significant in the high-dose group. However, ROCK I expression showed no statistically significant differences. Furthermore, the mRNA level of GRAF3 decreased dose-dependently. Apatinib administration was also associated with decreased levels of MLCP, and elevated endothelin-1 (ET-1) and collagen I, which were accompanied with increased mid-aortic media. However, treatment with Y27632 attenuated the above changes. CONCLUSION These findings suggest that activation of the RhoA/ROCK signaling pathway could be the underlying mechanism of apatinib-induced hypertension, while ROCK inhibitor have potential therapeutic value.
- Published
- 2021
- Full Text
- View/download PDF
36. Interfacial engineering with NiOx nanofibers as hole transport layer for carbon-based perovskite solar cells
- Author
-
Al Amin, Feng Yan, Lingyan Kong, S.N. Vijayaraghavan, Liping Guo, Xiao Han, Harigovind G. Menon, Jacob Wall, Xiaomeng Duan, Lin Li, and Yufeng Zheng
- Subjects
Electron mobility ,Auxiliary electrode ,Materials science ,Renewable Energy, Sustainability and the Environment ,business.industry ,Energy conversion efficiency ,chemistry.chemical_element ,chemistry ,Nanofiber ,Optoelectronics ,General Materials Science ,Chemical stability ,business ,Layer (electronics) ,Carbon ,Perovskite (structure) - Abstract
Although perovskite solar cells (PSCs) have made revolutionary progress in terms of power conversion efficiency (PCE), to achieve long-term stability and low-cost device manufacturing for commercialization of the devices, selection of proper hole transport layer (HTL) and affordable back contact are still crucial to realize the upscale manufacturing. However, the carbon-based perovskite still faces great challenges to further improve the device performance due to the low quality of the carbon/perovskite interface. Inorganic NiOx is a superior HTL candidate due to its favorable energy band alignment, superior chemical stability, high hole mobility, and low-cost manufacturing. To address the poor interface quality of the carbon-based PSCs, we report electrospun NiOx fibers as an effective HTL, resulting in highly efficient device performance of PCEs up to 13.73% when deployed in our carbon-based PSCs. NiOx has been introduced as an interfacial layer between the perovskite and the carbon counter electrode to study its impact on interfacial modification and device performance.
- Published
- 2021
- Full Text
- View/download PDF
37. Construction of an HCC recurrence model basedon the investigation of immune-relatedlncRNAs and related mechanisms
- Author
-
Wei Pan, Jing-Yi Ren, Liping Ai, Hong-Mei Zhang, Xiang-Xu Wang, Qiong Zhang, and Li-Hong Wu
- Subjects
Oncology ,medicine.medical_specialty ,recurrence ,Competing endogenous RNA ,business.industry ,Proportional hazards model ,Univariate ,immune microenvironment ,hepatocellular carcinoma ,ceRNA ,RM1-950 ,Nomogram ,medicine.disease ,Immune system ,lncRNA ,Internal medicine ,Hepatocellular carcinoma ,Drug Discovery ,Cohort ,Molecular Medicine ,Medicine ,Original Article ,Therapeutics. Pharmacology ,business ,Gene - Abstract
Long noncoding RNAs (lncRNAs) are emerging as critical regulators of gene expression and play fundamental roles in immune regulation. Growing evidence suggests that immune-related genes and lncRNAs can serve as markers to predict the prognosis of patients with cancers, including hepatocellular carcinoma (HCC). This study aimed to contract an immune-related lncRNA (IR-lncRNA) signature for prospective assessment to predict early recurrence of HCC. A total of 319 HCC samples under radical resection were randomly divided into a training cohort (161 samples) and a testing cohort (158 samples). In the training dataset, univariate, lasso, and multivariate Cox regression analyses identified a 9-IR-lncRNA signature closely related to disease-free survival. Kaplan-Meier analysis, principal component analysis, gene set enrichment analysis, and nomogram were used to evaluate the risk model. The results were further confirmed in the testing cohort. Furthermore, we constructed a competitive endogenous RNA regulatory network. The results of the present study indicated that this 9-IR-lncRNA signature has important clinical implications for improving predictive outcomes and guiding individualized treatment in HCC patients. These IR-lncRNAs and regulated genes may be potential biomarkers associated with the prognosis of HCC., Graphical abstract, In this paper, we applied multiple bioinformatics methods and constructed a 9-immune-related long noncoding RNA (IR-lncRNA) signature closely related to HCC recurrence. We further constructed an IR-lncRNA-associated competitive endogenous RNA (ceRNA) network based on multiple microRNA (miRNA) target databases. The hub genes in the ceRNA network may act as potential biomarkers and novel therapeutic targets for HCC.
- Published
- 2021
38. A new financial chaotic model in Atangana-Baleanu stochastic fractional differential equations
- Author
-
Sunil Kumar, Muhammad Altaf Khan, Chen Liping, and Abdon Atangana
- Subjects
Finance ,Financial chaotic system ,State variable ,business.industry ,Generalization ,020209 energy ,General Engineering ,Chaotic ,Equilibrium points ,02 engineering and technology ,Engineering (General). Civil engineering (General) ,01 natural sciences ,010305 fluids & plasmas ,Stochastic differential equation ,Operator (computer programming) ,Integer ,0103 physical sciences ,Numerical results ,0202 electrical engineering, electronic engineering, information engineering ,Exponent ,TA1-2040 ,Fractional differential ,business ,Mathematics - Abstract
We formulate and analyze a new financial chaotic model in fractional stochastic differential equation in Atangana-Baleanu operator. The model is constructed initially in integer case and then the application of fractional and stochastic approach are used for the model generalization. We study with care some of the mathematical results for the model in integer case by identifying the suitable values of parameters and initial values for the state variables for which the model behaves chaotic. Further, using the concept of stochastic differential equation, the model is further extended to the stochastic fractional differential equations. The equilibriums possibly the model posses are shown and analyzed. Lyapanove exponent are investigated for the model. We give a new method that is introduced recently in literature to find the model solution numerically for the case of fractional stochastic differential equation. We obtained many interesting graphical results for the model by considering different scenarios.
- Published
- 2021
- Full Text
- View/download PDF
39. Do COVID-19 pandemic-related behavior changes affect perioperative respiratory adverse events in children undergoing cardiac interventional catheterization?
- Author
-
Mazhong Zhang, Jijian Zheng, Wei Ji, Yue Huang, Mengqi Li, Siyuan Wang, Jie Bai, Liping Sun, and Kan Zhang
- Subjects
Heart Defects, Congenital ,medicine.medical_specialty ,China ,Cardiac Catheterization ,Coronavirus disease 2019 (COVID-19) ,business.industry ,Behavior change ,COVID-19 ,Perioperative ,Affect (psychology) ,Coronavirus ,Anesthesiology and Pain Medicine ,Emergency medicine ,Pandemic ,Medicine ,Humans ,Respiratory system ,business ,Adverse effect ,Child ,Coronavirus Infections ,Pandemics ,Respiratory Tract Infections - Abstract
Background The novel coronavirus disease (COVID-19) suddenly broke out in China in December 2019. Pandemic-related behavioral changes can cause perioperative respiratory adverse events in children with congenital heart disease (CHD). Here, we compared the incidence of perioperative respiratory adverse events (PRAEs) in CHD children with and without upper respiratory infection (URI) undergoing the cardiac catheterization before and during the COVID-19 pandemic. Methods This prospective observational single-center study was based at a tertiary care center in Shanghai, China. A total of 359 children with CHD with and without recent URI were included between January 2019 and March 2021. The overall incidence of PRAEs (laryngospasm, bronchospasm, coughing, airway secretion, airway obstruction, and oxygen desaturation) in non-URI and URI children undergoing elective cardiac catheterization was compared before and during the COVID-19 pandemic. A logistic regression model was fitted to identify the potential risk factors associated with PRAEs. Results Of the 564 children enrolled, 359 completed the study and were finally analyzed. The incidence of URIs decreased substantially during the COVID-19 pandemic (14% vs. 41%, P vs. 42.3%, P = 0.001 for non-URI and 29.2% vs. 58.7%, P = 0.012 for URI, respectively). Post-operative agitation in children without URI occurred less frequently during the pandemic than before (2.3% vs. 16.2%, P = 0.001). Behaviors before the COVID-19 pandemic (odds ratio = 2.84, 95% confidence interval [CI] 1.76–4.58) and recent URI (odds ratio = 1.79, 95% CI 1.09–2.92) were associated with PRAEs. Conclusions COVID-19 pandemic-related behavioral changes were associated with a reduction in PRAEs in non-URI and URI children undergoing elective therapeutic cardiac catheterization.
- Published
- 2022
- Full Text
- View/download PDF
40. Measures and Effects of Pain Management for Wound Dressing Change in Outpatient Children in Western China
- Author
-
Chen Liping, Wang Yan, Manish Sharma, Wu Yujie, Liping Wu, Lin Guangyan, and Yong Zhao
- Subjects
medicine.medical_specialty ,Lidocaine ,Analgesic ,03 medical and health sciences ,Wound care ,0302 clinical medicine ,children ,030202 anesthesiology ,Pain assessment ,medicine ,Journal of Pain Research ,Original Research ,lcsh:R5-920 ,integumentary system ,business.industry ,Pain management ,Ibuprofen ,Anesthesiology and Pain Medicine ,pain management ,Wound dressing ,Physical therapy ,Health education ,business ,lcsh:Medicine (General) ,030217 neurology & neurosurgery ,medicine.drug ,wound care - Abstract
Yujie Wu,1 Yong Zhao,2 Guangyan Lin,3 Manoj Sharma,4 Yan Wang,1 Liping Chen,1 Liping Wu1 1Department of Nursing, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing, People’s Republic of China; 2School of Public Health and Management, Chongqing Medical University, Chongqing, People’s Republic of China; 3Department of Outpatient Surgery, Children’s Hospital of Chongqing Medical University, Chongqing, People’s Republic of China; 4Environmental & Occupational Health, University of Nevada, Las Vegas, NV, USACorrespondence: Liping WuDepartment of Nursing, Children’s Hospital of Chongqing Medical University, National Clinical Research Center for Child Health and Disorders, Ministry of Education Key Laboratory of Child Development and Disorders, Chongqing Key Laboratory of Pediatrics, 136 Zhongshan 2nd Road, Yuzhong District, Chongqing, People’s Republic of ChinaTel +86 13883994594Email wulp312@163.comPurpose: The present study investigated the pain management of wound dressing change in outpatient children in western China, and the results may provide a reference to improve the pain management of wound dressing change.Methods: A cross-sectional survey was performed to investigate the pain management of wound dressing change in outpatient children in western China. A total of 47 hospitals were selected via convenience sampling, and the pain management organization systems, concrete measures and barriers to adequate pain management of these hospitals were investigated.Results: More than 70% of these hospitals had established pain management systems, analgesic drug management norms and wound care teams. Nurses were the primary providers for wound dressing change in 48.94% of the hospitals. The assessment, documentation or health education of the pain was not standard in 46.81% of the hospitals. Drug and non-drug analgesia measures were used in most hospitals, however, children did not receive adequate analgesia in 70% of the hospitals. Ibuprofen (30.49%) and lidocaine (29.27%) were commonly used analgesic drugs, and distraction (43.01%) was commonly used as a non-drug analgesia measure. The top three barriers to adequate pain management were medical staff lacking analgesic knowledge (82.98%), family members refusing to use analgesics (61.70%) and low compliance of children (55.32%).Conclusion: The concrete measures for the management of wound dressing pain in children are not standardized, and the analgesic effect is poor. In order to improve the pain management of children, Standardized procedures for pain management (pain assessment, analgesia measures, pain documentation and health education) should be strictly followed during wound dressing change, and the identified barriers should be addressed.Keywords: pain management, wound care, children
- Published
- 2021
41. Efficacy and safety of geptanolimab (GB226) for relapsed or refractory peripheral T cell lymphoma: an open-label phase 2 study (Gxplore-002)
- Author
-
Yuankai Shi, Jianqiu Wu, Zhen Wang, Liling Zhang, Zhao Wang, Mingzhi Zhang, Hong Cen, Zhigang Peng, Yufu Li, Lei Fan, Ye Guo, Liping Ma, Jie Cui, Yuhuan Gao, Haiyan Yang, Hongyu Zhang, Lin Wang, Weihua Zhang, Huilai Zhang, Liping Xie, Ming Jiang, Hui Zhou, Yuerong Shuang, Hang Su, Xiaoyan Ke, Chuan Jin, Xin Du, Li Liu, Yaming Xi, Zheng Ge, Ru Feng, Yang Zhang, Shengyu Zhou, Fan Xie, and Qian Wang
- Subjects
Male ,Cancer Research ,medicine.medical_specialty ,Phases of clinical research ,Kaplan-Meier Estimate ,Gastroenterology ,T cell lymphomas ,lcsh:RC254-282 ,Antineoplastic Agents, Immunological ,Refractory ,Internal medicine ,medicine ,Clinical endpoint ,Humans ,Adverse effect ,Immune Checkpoint Inhibitors ,Molecular Biology ,Aged ,Hematology ,business.industry ,lcsh:RC633-647.5 ,Research ,Lymphoma, T-Cell, Peripheral ,lcsh:Diseases of the blood and blood-forming organs ,Middle Aged ,medicine.disease ,lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,Peripheral T-cell lymphoma ,Clinical trial ,PD-1 inhibitor ,Treatment Outcome ,Oncology ,Toxicity ,Female ,Immunotherapy ,Neoplasm Recurrence, Local ,business - Abstract
Background Peripheral T cell lymphoma (PTCL) is a rare disease and recent approved drugs for relapsed/refractory (r/r) PTCL provided limited clinical benefit. We conducted this study to evaluate the efficacy and safety of geptanolimab (GB226), an anti-PD-1 antibody, in r/r PTCL patients. Methods We did this single-arm, multicenter phase 2 study across 41 sites in China. Eligible patients with r/r PTCL received geptanolimab 3 mg/kg intravenously every 2 weeks until disease progression or intolerable toxicity. All patients who received at least one dose of geptanolimab and histological confirmed PTCL entered full analysis set (FAS). The primary endpoint was objective response rate (ORR) in FAS assessed by the independent radiological review committee (IRRC) per Lugano 2014 criteria. Results Between July 12, 2018, and August 15, 2019, 102 patients were enrolled and received at least one dose of geptanolimab. At the data cutoff date (August 15, 2020), the median follow-up was 4.06 (range 0.30–22.9) months. For 89 patients in FAS, 36 achieved objective response (40.4%, 95% CI 30.2–51.4), of which 13 (14.6%) were complete response and 23 (25.8%) had partial response assessed by IRRC. The median duration of response (DOR) was 11.4 (95% CI 4.8 to not reached) months per IRRC. Patients with PD-L1 expression ≥ 50% derived more benefit from geptanolimab treatment compared to p = 0.013; median PFS 6.2 vs. 1.5 months, p = 0.002). Grade ≥ 3 treatment-related adverse events occurred in 26 (25.5%) patients, and the most commonly observed were lymphocyte count decreased (n = 4) and platelet count decreased (n = 3). Serious adverse events were observed in 45 (44.1%) patients and 19 (18.6%) were treatment related. Conclusions In this study, geptanolimab showed promising activity and manageable safety profile in patients with r/r PTCL. Anti-PD-1 antibody could be a new treatment approach for this patient population. Trial registration: This clinical trial was registered at the ClinicalTrials.gov (NCT03502629) on April 18, 2018.
- Published
- 2021
42. Systemic inflammatory indices predict tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer
- Author
-
Liang Huang, Shuangling Luo, Liping Wang, Sicong Lai, Jianghui Dong, Liang Kang, Zhanzhen Liu, Lai, Sicong, Huang, Liang, Luo, Shuangling, Liu, Zhanzhen, Dong, Jianghui, Wang, Liping, and Kang, Liang
- Subjects
0301 basic medicine ,Oncology ,Cancer Research ,medicine.medical_specialty ,Multivariate analysis ,Colorectal cancer ,colorectal cancer ,03 medical and health sciences ,0302 clinical medicine ,neoadjuvant chemoradiotherapy ,Internal medicine ,medicine ,Radical surgery ,Pathological ,Oncogene ,business.industry ,Cancer ,Articles ,medicine.disease ,Molecular medicine ,local advanced rectal cancer ,030104 developmental biology ,030220 oncology & carcinogenesis ,systemic inflammatory indices ,pathological complete response ,business ,Neoadjuvant chemoradiotherapy - Abstract
Systemic inflammatory responses are associated with the prognosis of patients with colorectal cancer. However, the value in predicting tumor responses to neoadjuvant chemoradiotherapy (nCRT) remains to be elucidated. The current study aimed to investigate the association between systemic inflammatory indices and pathological complete response (pCR). The training and validation cohorts included 225 and 96 patients with locally advanced rectal cancer. The neutrophil‑to‑lymphocyte ratio (NLR) and platelet‑to‑lymphocyte ratio were recorded prior to nCRT and radical surgery. Univariate and multivariate analysis were used to investigate the association between systemic inflammatory indices and pCR. Systemic inflammatory indices prior to or following treatment had no significant association with pCR; however, the percentage change in NLR from pre‑nCRT to post‑nCRT was associated with a poor response, and a percentage change of >21.5% NLR (P=0.006; OR=0.413; 95% CI=0.22‑0.773) was a predictor of poor pCR. Therefore, in rectal cancer, the percentage change in NLR from pre‑ to post‑nCRT was found to be a predictor of poor pCR. Refereed/Peer-reviewed
- Published
- 2020
43. Initial Invasive or Conservative Strategy for Stable Coronary Disease
- Author
-
Maron D. J., Hochman J. S., Reynolds H. R., Bangalore S., O'Brien S. M., Boden W. E., Chaitman B. R., Senior R., Lopez-Sendon J., Alexander K. P., Lopes R. D., Shaw L. J., Berger J. S., Newman J. D., Sidhu M. S., Goodman S. G., Ruzyllo W., Gosselin G., Maggioni A. P., White H. D., Bhargava B., Min J. K., John Mancini G. B., Berman D. S., Picard M. H., Kwong R. Y., Ali Z. A., Mark D. B., Spertus J. A., Krishnan M. N., Elghamaz A., Moorthy N., Hueb W. A., Demkow M., Mavromatis K., Bockeria O., Peteiro J., Miller T. D., Szwed H., Doerr R., Keltai M., Selvanayagam J. B., Gabriel Steg P., Held C., Kohsaka S., Mavromichalis S., Kirby R., Jeffries N. O., Harrell F. E., Rockhold F. W., Broderick S., Bruce Ferguson T., Williams D. O., Harrington R. A., Stone G. W., Rosenberg Y, ISCHEMIA Research Group: Joseph Ricci, A Tello Montoliu, A I Robero Aniorte, Abbey Mulder, Abhay A Laddu, Abhinav Goyal, Abhishek Dubey, Abhishek Goyal, Abigail Knighton, Abraham Oomman, Adam J Jaskowiak, Adam Kolodziej, Adam Witkowski, Adnan Hameed, Adriana Anesini, Afshan Hussain, Agne Juceviciene, Agne Urboniene, Agnes Jakal, Agnieszka Szramowska, Ahmad Khairuddin, Ahmed Abdel-Latif, Ahmed Adel, Ahmed Aljzeeri, Ahmed Kamal, Ahmed Talaat, Aimee Mann, Aira Contreras, Ajit Kumar, V K Kumar, Akemi Furukawa, Akshay Bagai, Akvile Smigelskaite, Alain Furber, Alain Rheault, Alaine Melanie Loehr, Alan Rosen, Albert Varga, Albertina Qelaj, Alberto Barioli, Aldo Russo, Alec Moorman, Alejandro Gisbert, Aleksandra Fratczak, Aleksandras Laucevicius, Alena Kuleshova, Alessandro Sionis, Alexander A Sirker, Alexander M Chernyavskiy, Alexandra Craft, Alexandra Vazquez, Alexandre Ciappina Hueb, Alexandre S Colafranseschi, Alexandre Schaan de Quadros, Alexandre Tognon, Ali Alghamdi, Alice Manica Muller, Aline Nogueira Rabaça, Aline Peixoto Deiro, Alison Hallam, Allegra Stone, Allison Schley, Almudena Castro, Alvaro Rabelo Ales, Amanda Germann, Amanda O'Malley, Amar Uxa, Amarachi Ojajuni, Amarino C Oliveira Jr, Amber B Hull, Ambuj Roy, Amer Zarka, Amir Janmohamed, Ammani Brown, Ammy Malinay, Amparo Martinez Monzonis, Amy J Richards, Amy Iskandrian, Amy Ollinger, Ana D Djordjevic-Dikic, Ana Fernández Martínez, Ana Gomes Almeida, Ana Paula Batista, Ana Rita Francisco, Ana S Mladenovic, Ana Santana, Anam Siddiqui, Anastasia M Kuzmina-Krutetskaya, Andras Vertes, Andre S Sousa, Andre Gabriel, André Schmidt, Andrea M Lundeen, Andrea Bartykowszki, Andrea Lorimer, Andrea Mortara, Andrea Pascual, Andreia Coelho, Andreia Rocha, Andrés García-Rincón, Andrew G Howarth, Andrew J Moriarty, Andrew Docherty, Andrew Starovoytov, Andrew Zurick, Andrzej Łabyk, Andrzej Swiatkowski, Andy Lam, Anelise Kawakami, Angela Hoye, Angela Kim, Angelique Smit, Angelo Nobre, Anil V Shah, Anja Ljubez, Anjali Anand, Ankush Sachdeva, Ann Greenberg, Ann Luyten, Ann Ostrander, Anna Di Donato, Anna Cichocka-Radwan, Anna Fojt, Anna Plachcinska, Anna Proietti, Anna Teresinska, Anne Marie Webb, Anne Cartwright, Anne Heath, Anne Mackin, Anong Amaritakomol, Anong Chaiyasri, Anoop Chauhan, Anoop Mathew, Anthony Gemignani, Anto Luigi Andres, Antonia Vega, Antonietta Hansen, Antonino Ginel Iglesias, Antonio Carlos Carvalho, Antonio Di Chiara, Antonio Serra Peñaranda, Antonio Carvalho, Antonio Colombo, Antonio Fiarresga, Anupama Rao, Aquiles Valdespino-Estrada, Araceli Boan, Areef Ishani, Ariel Diaz, Arijit Ghosh, Arintaya Prommintikul, Arline Roberts, Arnold H Seto, Arnold P Good, Arshed Quyyumi, Arthur J Labovitz, Arthur Kerner, Arturo S Campos-Santaolalla, Arunima Misra, Ashok Mukherjee, Ashok Seth, Ashraf Seedhom, Asim N Cheema, Asker Ahmed, Atul Mathur, Atul Verma, Audrey W Leong, Axel Åkerblom, Axelle Fuentes, Aynun Naher, Badhma Valaiyapathi, Baljeet Kaur, Bandula Guruge, Barbara Brzezińska, Barbara Nardi, Bartosz Czarniak, Bebek Singh, Begoña Igual, Bela Merkely, Belen Cid Alvarez, Benjamin J Spooner, Benjamin J W Chow, Benjamin Cheong, Benoy N Shah, Bernard de Bruyne, Bernardas Valecka, Bernhard Jäger, Beth A Archer, Beth Abramson, Beth Jorgenson, Bethany Harvey, Betsy O'Neal, Bev Atkinson, Bev Bozek, Bevin Lang, Bijulal Sasidharan, Bin Yang, Bin Zhang, Binoy Mannekkattukudy Kurian, Bjoern Goebel, Bob Hu, Bogdan A Popescu, Bogdan Crnokrak, Bolin Zhu, Bonnie J Kirby, Brandi D Zimbelman, Brandy Starks, Branko D Beleslin, Brenda Hart, Brian P Shapiro, Brian McCandless, Brianna Wisniewski, Brigham R Smith, Brooks Mirrer, Bruce McManus, Bruce Rutkin, Bruna Edilena Paulino, Bruna Maria Ascoli, Bryn Smith, Byron J Allen, C Michael Gibson, C Noel Bairey Merz, Calin Pop, Cameron Hague, Camila Thais de Ormundo, Candace Gopaul, Candice P Edillo, Carísi A Polanczyk, Carita Krannila, Carla Vicente, Carl-Éric Gagné, Carlo Briguori, Carlos Peña Gil, Carlos Alvarez, Carly Ohmart, Carmen C Beladan, Carmen Ginghina, Carol M Kartje, Caroline Alsweiler, Caroline Brown, Caroline Callison, Caroline Pinheiro, Caroline Rodgers, Caroline Spindler, Carolyn Corbett, Carrie Drum, Casey Riedberger, Catherine Bone, Catherine Fleming, Catherine Gordon, Catherine Jahrsdorfer, Catherine Lemay, Catherine Weick, Cathrine Patten, Cecilia Goletto, Cezary Kepka, Chandini Suvarna, Chang Xu, Chantale Mercure, Charle A Viljoen, Charlene Wiyarand, Charles Jia-Yin Hou, Charles Y Lui, Charles Cannan, Charles Cornet, Charlotte Pirro, Chataroon Rimsukcharoenchai, Chen Wang, Cheng-Ting Tsai, Chen-Yen Chien, Cheryl A Allardyce, Chester M Hedgepeth, Chetan Patel, Chiara Attanasio, Chih-Hsuan Yen, Chi-Ming Chow, Ching Min Er, Ching-Ching Ong, Cholenahally Nanjappa Manjunath, Chris Beck, Chris Buller, Christel Vassaliere, Christian Hamm, Christiano Caldeira, Christie Ballantyne, Christina Björklund, Christine R Hinton, Christine Bergeron, Christine Masson, Christine Roraff, Christine Shelley, Christophe Laure, Christophe Thuaire, Christopher Kinsey, Christopher McFarren, Christopher Spizzieri, Christopher Travill, Chun-Chieh Liu, Chung-Lieh Hung, Chunguang Li, Chun-Ho Yun, Chunli Xia, Ciarra Heard, Cidney Schultz, Clare Venn-Edmonds, Claudia P Hochberg, Claudia Wegmayr, Claudia Cortés, Claudia Escobar, Cláudia Freixo, Claudio T Mesquita, Clemens T Kadalie, Colin Berry, Constance Philander, Corine Thobois, Costantino Costantini, Courtney Page, Craig Atkinson, Craig Barr, Craig Paterson, Cristina Bare, Cynthia Baumann, Cynthia Burman, Dalisa Espinosa, Damien Collison, Dan Deleanu, Dan Elian, Dan Gao, Dana Oliver, Daniel P Vezina, Daniel O'Rourke, Daniele Komar, Danielle Schade, Darrel P Francis, Dastan Malaev, David A Bull, David E Winchester, David P Faxon, David Booth, David Cohen, David DeMets, David Foo, David Schlichting, David Taggart, David Waters, David Wohns, Davis Vo, Dawid Teodorczyk, Dawn Shelstad, Dawn Turnbull, Dayuan Li, Dean Kereiakes, Deborah O'Neill, Deborah Yip, Debra K Johnson, Debra Dees, Deepak L Bhatt, Deepika Gopal, Deepti Kumar, Deirdre Mattina, Deirdre Murphy, Delano R Small, Delsa K Rose, Dengke Jiang, Denis Carl Phaneuf, Denise Braganza, Denise Fine, Derek Cyr, Desiree Tobin, Diana Cukali, Diana Parra, Diane Camara, Diane Minshall Liu, Diego Adrián Vences, Diego Franca de Cunha, Dimitrios Stournaras, Dipti Patel, Dongze Li, Donna Exley, Dorit Grahl, Dragana Stanojevic, Duarte Cacela, Dwayne S G Conway, E Pinar Bermudez, Eapen Punnoose, Edgar L Tay, Edgar Karanjah, Edoardo Verna, Eduardo Hernandez-Rangel, Edward D Nicol, Edward O McFalls, Edward T Martin, Edyta Kaczmarska, Ekaterina I Lubinskaya, Elena A Demchenko, Elena Refoyo Salicio, Eli Feen, Elihú Durán-Cortés, Elisabeth M Janzen, Elise L Hannemann, Elise van Dongen, Elissa Restelli Piloto, Eliza Kaplan, Elizabeta Srbinovska Kostovska, Elizabeth Capasso-Gulve, Elizabeth Congdon, Elizabeth Ferguson, Elizaveta V Zbyshevskaya, Ellen Magedanz, Ellie Fridell, Ellis W Lader, Elvin Kedhi, Emanuela Racca, Emilie Tachot, Emily DeRosa, Encarnación Alonso-Álvarez, Eric Nicollet, Eric Peterson, Erick Alexánderson Rosas, Erick Donato Morales, Erin Orvis, Ermina Moga, Estelle Montpetit, Estevao Figueiredo, Eugene Passamani, Eugenia Nikolsky, Eunice Yeoh, Evgeniy I Kretov, Ewa Szczerba, Ewelina Wojtala, Expedito Eustáquio Ribeiro Silva, F Marin Ortuño, Fabio R Farias, Fabio Fimiani, Fabrizio Rolfo, Fa-Chang Yu, Fadi Hage, Fadi Matar, Fahim Haider Jafary, Fang Feng, Fang Liu, Fatima Ranjbaran, Fatima Rodriguez, Fausto J Pinto, Fauzia Rashid, Federica Ramani, Fei Wang, Fernanda Igansi, Filipa Silva, Filippo Ottani, Fiona Haines, Firas Al Solaiman, Flávia Egydio, Flavio Lyra, Florian Egger, Fran Farquharson, Frances Laube, Francesc Carreras Costa, Francesca de Micco, Francesca Bianchini, Francesca Pezzetta, Francesca Pietrucci, Francesco Orso, Francesco Pisano, Francis Burt, Francisca Patuleia Figueiras, Francisco Fernandez-Aviles, Francois Pierre Mongeon, Frans Van de Werf, Franziska Guenther, Fraser N Witherow, Fred Mohr, Frederico Dall'Orto, Fumiyuki Otsuka, G De La Morena, G Karthikeyan, Gabor Dekany, Gabor Kerecsen, Gabriel Galeote, Gabriel Grossmann, Gabriel Vorobiof, Gabriela Sanchez de Souza, Gabriela Guzman, Gabriela Zeballos, Gabriele Gabrielli, Gabriele Jakl-Kotauschek, Gail A Shammas, Gail Brandt, Gang Chen, Gary E Lane, Gary J Luckasen, Gautam Sharma, Gelmina Mikolaitiene, Gennie Yee, Georg Nickenig, George E Revtyak, George J Juang, Gerald Fletcher, Gerald Leonard, Gerard Patrick Devlin, Gerard Esposito, Gergely Ágoston, Gervasio Lamas, Geza Fontos, Ghada Mikhail, Gia Cobb, Gian Piero Perna, Gianpiero Leone, Giles Roditi, Gilles Barone-Rochette, Girish Mishra, Giuseppe Tarantini, Glenda Wong, Glenn S Hamroff, Glenn Rayos, Gong Cheng, Gonzalo Barge-Caballero, Goran Davidović, Goran Stankovic, Gordana Stevanovic, Grace Jingyan Wang, Grace M Young, Graceanne Wayser, Graciela Scaro, Graham S Hillis, Graham Wong, Grazyna Anna Szulczyk, Gregor Simonis, Gregory Kumkumian, Gretchen Ann Peichel, Grzegorz Gajos, Gudrun Steinmaurer, Guilherme G Rucatti, Guilherme Portugal, Guilhermina Cantinho Lopes, Guillem Pons Lladó, Gunnar Frostfelt, Gurpreet S Wander, Gurpreet Gulati, Gustavo Pucci, Hafidz Abd Hadi, Haibo Zhang, Haitao Wang, Halina Marciniak, Han Chen, Hanan Kerr, Hani Najm, Hanna Douglas, Hannah Phillips, Hao Dai, Haojian Dong, Haqeel Jamil, Harikrishnan Sivadasanpillai, Harry Suryapranata, Hassan Reda, Hayley Pomeroy, Heather Barrentine, Heather Golden, Heather Hurlburt, Heidi Wilson, Helen C Tucker, Helene Abergel, Hemalata Siddaram, Hermine Osseni, Herwig Schuchlenz, Hesong Zeng, Hicham Skali, Hilda Solomon, Hollie Horton, Holly Hetrick, Holly Little, Holly Park, Hongjie Chi, Hossam Mahrous, Howard A Levite, Hristo Pejkov, Huajun Li, Hugo Bloise-Adames, Hugo Marques, Hui Zhong, Hui-Min Zhang, Humayrah Hashim, Hung-I Yeh, Hussien El Fishawy, Ian Webb, Iftikhar Kullo, Igor O Grazhdankin, Ihab Hamzeh, Ikraam Hassan, Ikuko Ueda, Ileana L Pina, Ilona Tamasauskiene, Ilse Bouwhuis, Imran Arif, Ina Wenzelburger, Inês Zimbarra Cabrita, Ines Rodrigues, Inga H Robbins, Inga Soveri, Ingela Schnittger, Iqbal Karimullah, Ira M Dauber, Iram Rehman, Irena Peovska Mitevska, Irene Marthe Lang, Irina Subbotina, Irma Kalibataite-Rutkauskiene, Irni Yusnida, Isabel Estela Carvajal, Isabella C Palazzo, Isabelle Hogan, Isabelle Roy, Ishba Syed, Ishita Tejani, Ivan A Naryshkin, Ivana Jankovic, Iwona Niedzwiecka, J David Knight, Jacek Kusmierek, Jackie M White, Jackie Chow, Jacob Udell, Jacqueline E Tamis-Holland, Jacqueline Fannon, Jacquelyn A Quin, Jacquelyn Do, Jaekyeong Heo, Jakub Maksym, James E Davies, James H O'Keefe Jr, James J Jang, James Cha, James Harrison, James Hirsch, James Stafford, James Tatoulis, Jamie Rankin, Jan Henzel, Jan Orga, Jana Tancredi, Janaina Oliveira, Jane Burton, Jane Eckstein, Jane Marucci, Janet P Knight, Janet Blount, Janet Halliday, Janetta Kourzenkova, Janitha Raj, Jan-Malte Sinning, Jaqueline Pozzibon, Jaroslaw Drozdz, Jaroslaw Karwowski, Jason D Glover, Jason Loh Kwok, Jason T Call, Jason Linefsky, Jassira Gomes, Jati Anumpa, Javier J Garcia, Javier Courtis, Jay Meisner, K Jayakumar, Jayne Scales, Jean E Denaro, Jean Michel Juliard, Jean Ho, Jeanette K Stansborough, Jean-Michel Juliard, Jeanne Russo, Jeannette J M Schoep, Jeet Thambyrajah, Jeff Leimberger, Jeffery A Breall, Jeffrey A Kohn, Jeffrey C Milliken, Jeffrey Anderson, Jeffrey Blume, Jeffrey Kanters, Jeffrey Lorin, Jeffrey Moses, Jelena J Stepanovic, Jelena Celutkiene, Jelena Djokic, Jelena Stojkovic, Jenne M Jose, Jenne Manchery, Jennifer A Mull, Jennifer H Czerniak, Jennifer L Stanford, Jennifer Gillis, Jennifer Horst, Jennifer Isaacs, Jennifer Langdon, Jennifer Thomson, Jennifer Tomfohr, Jennifer White, Jen-Yuan Kuo, Jeremy Rautureau, Jerome Fleg, Jessica Berg, Jessica Rodriguez, Jessica Waldron, Jhina Patro, Jia Li, Jiajia Mao, Jiamin Liu, Jian'an Wang, Jianhua Li, Jianxin Zhang, Jie Qi, Jihyun Lyo, Jill Marcus, Jim Blankenship, Jing Zhang, Jingjing Liu, Jing-Yao Fan, Jiun-Yi Li, Jiwan Pradhan, Jiyan Chen, J M Rivera Caravaca, Jo Evans, Joan Garcia Picart, Joan Hecht, Joanna Jaroch, Joanna Zalewska, Joanne Kelly, Joanne Taaffe, João Reynaldo Abbud, João V Vitola, Joaquín V Peñafiel, Jocelyne Benatar, Jody Bindeman, Joe Sabik, Joel Klitch, Johann Christopher, Johannes Aspberg, John D Friedman, John F Beltrame, John F Heitner, John Joseph Graham, John R Davies, John Doan, John Kotter, John Kurian, John Mukai, John Pownall, Jolanta Sobolewska, Jon Kobashigawa, Jonathan L Goldberg, Jonathan W Bazeley, Jonathan Byrne, Jonathan Himmelfarb, Jonathan Leipsic, Jonean Thorsen, Jorge F Trejo Gutierrez, Jorge Escobedo, Jorik Timmer, José A Ortega-Ramírez, José Antonio Marin-Neto, Jose D Salas, Jose Enrique Castillo, Jose Francisco Saraiva, José J Cuenca-Castillo, Jose L Diez, José Luis Narro Villanueva, José Luiz da Vieira, José M Flores-Palacios, Jose Ramon Gonzalez, Jose Seijas Amigo, Jose Fragata, Josep Maria Padró, Josheph F X McGarvey Jr, Joseph Hannan, Joseph Sacco, Joseph Sweeny, Joseph Wiesel, Josephine D Abraham, Joshua P Loh, Joy Burkhardt, Joyce R White, Joyce Riestenberg-Smith, Judit Sebo, Judith L Meadows, Judith Wright, Judy Mae Foltz, Judy Hung, Judy Otis, Juergen Stumpf, Jui-Peng Tsai, Julia S Dionne, Julia de Aveiro Morata, Julie Bunke, Julie Morrow, Julio César Figal, Jun Fujita, Jun Jiang, Junhua Li, Junqing Yang, Juntima Euathrongchit, Jyotsna Garg, K Manjula Rani, K Preethi, Kaatje Goetschalckx, Kai Eggers, Kamalakar Surineni, Kanae Hirase, T R Kapilamoorthy, Karen Calfas, Karen Gratrix, Karen Hallett, Karen Hultberg, Karen Nugent, Karen Petrosyan, Karen Swan, Karolina Kryczka, Karolina Wojtczak-Soska, Karolina Wojtera, Karsten Lenk, Karthik Ramasamy, Katarzyna Łuczak, Katarzyna Malinowska, Kate Pointon, Kate Robb, Katherine Martin, Kathleen Claes, Kathryn Carruthers, Kathy E Siegel, Katia Drouin, Katie Fowler-Lehman, Kavita Rawat, Kay Rowe, Keiichi Fukuda, Keith A A Fox, Ken Mahaffey, Kendra Unterbrink, Kenneth Giedd, Kerrie Van Loo, Kerry Lee, Kerstin Bonin, Kevin R Bainey, Kevin T Harley, Kevin Anstrom, Kevin Chan, Kevin Croce, Kevin Landolfo, Kevin Marzo, Keyur Patel, Khaled Abdul-Nour, Khaled Alfakih, Khaled Dajani, Khaled Ziada, Khaula Baloch, Khrystyna Kushniriuk, Kian-Keong Poh, Kim F Ireland, Kim Holland, Kimberly Ann Byrne, Kimberly E Halverson, Kimberly Elmore, Kimberly Miller-Cox, Kiran Reddy, Kirsten J Quiles, Kirsty Abercrombie, Klaus Matschke, Konrad Szymczyk, Koo Hui Chan, Kotiboinna Preethi, Kozhaya Sokhon, Krissada Meemuk, Kristian Thygesen, Kristin M Salmi, Kristin Newby, Kristina Wippler, Kristine Arges, Kristine Teoh, Krystal Etherington, Krystyna Łoboz-Grudzień, Krzysztof W Reczuch, Krzysztof Bury, Krzysztof Drzymalski, Krzysztof Kukuła, Kuo-Tzu Sung, Kurt Huber, Ladda Douangvila, Lance Sullenberger, Larissa Miranda Trama, Laszlone Matics, Laura Drew, Laura Flint, Laura Keinaite, Laura Sarti, Laurel Kolakaluri, Lawrence M Phillips, Lawrence Friedman, Lawrence Phillips, Lazar Velicki, Leah Howell, Leandro C Maranan, Leanne Cox, Ledjalem Daba, Lei Zhang, Lekshmi Dharmarajan, Leo Bockeria, Leonardo Pizzol Caetano, Leonardo Bridi, Leonid L Bershtein, Leszek Sokalski, Li Hai Yan, Li Li, Lia Nijmeijer, Lidia Sousa, Lihong Xu, Lihua Zhang, Lili Zhang, Lilia Schiavi, Lilian Mazza Barbosa, Lillian L Khor, Lina Felix-Stern, Linda L Hall, Linda M Hollenweger, Linda Arcand, Linda Davidson-Ray, Linda Schwarz, Lindsey N Sikora, Lingping Chi, Lino Patricio, Liping Zhang, Lisa Chaytor, Lisa Hatch, Lisa McCloy, Lisa Wong, Liselotte Persson, Lixin Jiang, Liz Low, Ljiljana Pupic, Loïc Bière, Lorenzo Monti, Lori Christensen, Lori Pritchard, Loriane Black, Lori-Ann Desimone, Lori-Ann Larmand, Lorraine McGregor, Louise Morby, Louise Thomson, Luc Harvey, Luciana de Pádua Baptista, Lucilla Garcia, Ludivine Eliahou, Ludmila Helmer, Luis F Smidt, Luis Bernanrdes, Luis Guzman, Luiz A Carvalho, Luyang Xiong, Lynette L Teo, Lynn M Neeson, Lynne Winstanley, M Barbara Srichai-Parsia, M Quintana Giner, M Sowjanya Reddy, M Valdés Chávarri, M Grazia Rossi, Maarten Simoons, Maayan Konigstein, Maciej Lesiak, Maciej Olsowka, Mafalda Selas, Magalie Corfias, Magdalena Madero Rovalo, Magdalena Łanocha, Magdalena Miller, Magdalena Misztal-Teodorczyk, Magdalena Rantinella, Magdy Abdelhamid, Magnolia Jimenez, Mahboob Alam, Mahevamma Mylarappa, Mahfouz El Shahawy, Mahmoud Mohamed, Mahmud Al-Bustami, Majo X Joseph, Malgorzata Frach, Małgorzta Celińska-Spodar, Malte Helm, Manas Chacko, Mandy Murphy, Manitha Vinod, Manjula Rani, Manu Dhawan, Manuela Mombelli, Marcel Weber, Marcello Galvani, Marcelo Jamus Rodrigues, Marcia F Dubin, Marcia F Werner Bayer, Marcin Szkopiak, Marco Antonio Monsalve, Marco Bizzaro Santos, Marco Magnoni, Marco Marini, Marco Sicuro, Marco Zenati, Marcos Valério Coimbra Resende, Marek Roik, Margalit Bentzvi, Margaret Gilsenan, Margaret Iraola, Margot C Quinn, Maria A Alfonso, Maria Antonieta Pereira Moraes, María Dolores Martínez-Ruíz, María Fernanda Canales, Maria Inês Caetano, Maria P Corral, Maria Pérez García, Maria Victoria Actis, Maria Aguirre, Maria Andreasson, Maria Aprile, Maria Colton, Maria Eugenia Martin, Maria Lasala, Maria Lorenzo, Maria Posada, Maria Shier, Maria Thottam, Mariana V Furtado, Mariana Yumi Okada, Marianna D A Dracoulakis, Marianne De Andrade, Mariano Rubio, Marie Essermark, Marielle Scherrer-Crosbie, Marija T Petrovic, Marija Zdravkovic, Marilyn Black, Marina Garcia, Mario J Garcia, Mariola Szulik, Marisa Orgera, Mark A de Belder, Mark Harbinson, Mark Hyun, Mark Peterson, Mark Xavier, Marlowe Mosley, Marta Capinha, Marta Marcinkiewicz-Siemion, Marta Swiderek, Martha Meyer, Martina Ceseri, Martina Tricoli, Marvin Kronenberg, Mary Williams, Mary Ann Champagne, Mary Colleen Rogge, Mary R Soltau, Mary Streif, Massimo Villella, Massoud Leesar, Matei Claudia, Mateusz Solecki, Matías Nicolás Mungo, Matthew Wall Jr, Matthew Budoff, Matthew Jezior, Matthew Luckie, Matthias Friedrich, Mauren P Haeffner, Maximilian Tscharre, Max-Paul Winter, Mayana Almeida, Mayil S Krishnam, Mayuri Patel, Meenakshi Mishra, Megan Manocchia, Meghana Kakade, Melanie J Munro, Melissa D Chaplin, Melissa LeFevre, Mervyn Andiapen, Michael A Gibson, Michael B Rubens, Michael C Turner, Michael D Shapiro, Michael W Lee, Michael Berlowitz, Michael Davidson, Michael Mack, Michael McDaniel, Michael Mumma, Michal Wlodarczyk, Michel G Khouri, Michel S Slama, Michele Rawlins, Michelle M Bonner, Michelle M Seib, Michelle Chang, Michelle Crowder, Michelle Dixon, Michelle Mayon, Michelle McEvoy, Michelle Yee, Miguel M Fernandes, Miguel Nobre Menezes, Miguel Souto Bayarri, Miguel Barrero, Mikhail T Torosoff, Milan R Dobric, Milan Dobric, Milica Nikola Dekleva, Milind Avdhoot Gadkari, Millie Gomez, Min Tun Kyaw, Miriam Brooks, Miroslav Stevo Martinovic, Mitchel B Lustre, Mohammad Tariq Vakani, Mohammad El-Hajjar, Mohammed Al-Amoodi, Mohammed Hussain, Mohammed Saleem, Moisés Blanco-Calvo, Moisés Jiménez-Santos, Mona Bhatia, Monica Rosca, Monika Laukyte, Montserrat Gracida Blanca, Montserrat Vila Perales, Mouaz H Al-Mallah, Moysés de Oliveira Filho, Mpiko Ntsekhe, Muhamed Saric, Mulei Chen, Myriam Brousseau, Myrthes Emy Takiuti, Nada Cemerlic-Adjic, Nadia Asif, Nadia Gakou, Nafisa Hussain, Nana O Katamadze, Nancy L Clapp, Nancy Aedy, Nandita Nataraj, Nanette K Wenger, Naomi Uchida, Nasrul Ismail, Natalia S Oliveira, Natalia de Carvalho Maffei, Natalie Spitzer, Natasha C Putnam, Naved Aslam, Neamat Mowafy, Neeraj Pandit, Neeraj Parakh, Nevena Garcevic, Ngaire Meadows, Nhi N Tran, Nicholas Danchin, Nicki Lakeman, Nicola Johnston, Nicolas W Shammas, Nicole Saint Vrestil, Nicole Deming, Nier Zhong, Niket Patel, Nikola N Boskovic, Nikolaos Karogiannis, Nikos Werner, Nina Johnston, Ning Zhang, Ning Zhou, Niree Hindoyan, Nirmal Kumar, Nitika Chadha, Nitish Naik, Nodira Aripova, Noloyiso Mtana, Nona A Eskelson, Noor Syamira Mokhtar, Noppon Taksaudom, Nor Asiah Basri, Nora Marchelletta, Norma Hogg, Nungshi Jungla, Nuno Ferreira, Oksana A Lubyanaya, Olga B Nikolaeva, Olga Cañavate, Olga Sobrino, Olga Walesiak, Olga Walter, Olga Zdończyk, Olivia J Lim, Olivia Anaya, Olivia Mancilla, Olivier Dubourg, Olugbenga Bello, Omar Almousalli, Omar Thompson, Oni Olurinde, Or Harel, Osama Raheem, Oscar Méndiz, Óscar Prada-Delgado, Oz Shapira, P Christian Schulze, Pachara Panpunuan, Pal Maurovich-Horvat, Pallav Garg, Paloma Moraga, Pam Singh, Pamela Julian, Pamela Ouyang, Pamela Sigel, Pamela Woodard, Panpan Zhou, Paola Emanuela Poggio, Paola Smanio, Paolo Calabro, Paramjit Jeetley, Pascal Goube, Patricia K Nguyen, Patricia Alarie, Patricia Arakelian, Patricia Arsenault, Patricia Blaise, Patricia Brito, Patricia Cowper, Patricia Endsley, Patricia Mieses, Patrick B Alexander, Patrick Donnelly, Patrick Wilmot, Patrycja Lebioda, Paul C Gordon, Paul Der Mesropian, Paul Galiwango, Paul Hauptman, Paul Kennedy, Paula Beardsley, Paula García-González, Paulo Cury Rezende, Paulo Ricardo Caramori, Pavel S Kozlov, Pedro Canas Silva, Pedro Gabriel Melo Barros E Silva, Pedro Píccaro de Oliveira, Pedro Carvalho, Pedro Modas, Pedro Rio, Peeyush Jain, Peiyu He, Peter A McCullough, Peter H Stone, Peter M Pollak, Peter Douglass, Peter Henriksen, Peter OKane, Peter Ong, Philip Jones, Philip Rogal, Philippe Généreux, Philippe Menasche, Philippe Rheault, Phoebe Goold, Pierre Gervais, Pierre Michaud, Pilar Calvillo, Ping Chai, Piotr Jakubowski, Piotr Pruszczyk, Piotr Slomka, Piyamitr Sritara, Poay-Huan Loh, Poonam Sonawane, Pouneh Samadi, Pragnesh P Parikh, Prakash Deedwania, Pranav M Patel, Praneeth Polamuri, Pratiksha Sharma, Precilia Vasquez, Preeti Kamath, Prince Thomas, Priyadarshani Arambam, Puja K Mehta, Purvez Grant, Pushpa Naik, Qi Zhong, Qian Zhao, Qiang Zhou, Qianqian Yuan, Qin Yu, Qingxian Li, Qiulan Xie, Qiutang Zeng, R J Vindhya, R James Gerlach, Rachel King, Rada Vučić, Radmila Lyubarova, Radoslaw Pracon, Raewyn Fisher, Rafael Beyar, Rafael Diaz, Rafael Selgas, Raffaele Bugiardini, Raffaele Fanelli, Raisa Kavalakkat, V S Rajalekshmi, Rajat S Barua, Rajeev Menon, Rajesh Gopalan Nair, Rajesh Francis, Rajiv Narang, Rakesh Yadav, Ralph Alan Huston, T Ramakrishnan, Ramesh de Silva, Rami El Mahmoud, Ramiro Carvalho, Ramon de Jesús-Pérez, Ramona Stevens, Ran Leng, Ranjan Kachru, Ranjit Kumar Nath, Raquel Sanchez, Raven R Dwyer, Raven Lee, Ray Wyman, Raymond C Wong, Raymond W Little, Raymundo Ocaranza Sanchez, Rebecca J Wimmer, Rebecca Bariciano, Rebecca Otis, Rebekah R Herrmann, Reem Yunis, Reinette Hampson, Renato Abdala Karam, Renee C Hessian, Renee Kaneshiro, Reshma Ravindran, Reto Andreas Gamma, Reyna Bhandari, Reza Arsanjani, Ricardo L Lopes, Ricardo Mendes Oliveira, Ricardo Costa, Richa Bhatt, Richard F Davies, Richard H J Trimlett, Richard Goldweit, Rik Hermanides, Rine Nakanishi, Rinu R Sidh, Risha Patel, Rita Coram, Rizwan A Siddiqui, Rob S Beanlands, Robert J Hamburger, Robert K Riezebos, Robert M Donnino, Robert Bojar, Robert Chilton, Robert Guyton, Robert Henderson, Robert Kornberg, Robert Leber, Robert Mao, Robert Stenberg, Roberta P Santos, Roberto René Favaloro, Roberto Amati, Rodolfo G S D Lima, Rodrigo J Cerci, Rogerio Tumelero, Rohit Tandon, Roma Tewari, Romalisa Miranda-Peats, Ron Wald, Ronald A Mastouri, Ronald G Morford, Ronald G Schwartz, Ronald P Pedalino, Rongrong Hu, Ronnell A Hansen, Ronny A Cohen, Rory Hachamovitch, Rosa Homem, Rosa Sandonato, Rosane Laimer, Rosann Gans, Roxanne Yost, Roy Mathew, Rubén Baleón-Espinosa, Ruben Ramos, Rubine Gevorgyan, Rui Ferreira, Rui Jing, Ruth Pérez-Fernández, S K Dwivedi, S Ramakrishnan, Saadat Khan, Sabahat Bokhari, Sabu Thomas, Sadath Lubna, Sajeeda Parveen Khan, Sajeev Chakanalil Govindan, Saket Girotra, Saleem Kassam, Sallie Canada, Salvador Cruz-Flores, Samaa Mohamed, Samantha Ly, Sameh El Kaffas, Samia Massalha, Sampoornima Setty, Samuel Nwosu, Sandeep Seth, Sandeep Singh, Sander R Niehe, Sandra M Rivest, Sandra S Zier, Sandra Ahoud, Sandy Carr, Sanjay Ganapathi, Sanjay Shetty, Sanjeev Sharma, Santa Jimenez, Santhosh Satheesh, Santiago A Garcia, Sara Fernandez, Sara Karlsson, Sara Salkind, Sara Temiyasathit, Sarah Medina Rodriguez, Sarah Beaudry, Sarah Hadjih, Sarah Williams, Sarah Zahrani, Sarju Ralhan, Sasa Hinic, Sasko Kedev, Satinder Singh, Satoshi Yasuda, Satvic Cholenahally Manjunath, Sau Lee, Scott M Kaczkowski, Scott Kinlay, Sean W Hayes, Sebastian Sobczak, Senait Asier, Sergey A Sayganov, Seth I Sokol, Shaheen Pandie, Shaiful Azmi Yahaya, Shamir Mehta, Shao-Ping Nie, Sharad Chandra, Sharder Islam, Sharon Tai, Sheetal Rupesh Karwa, Sheri Ussery, Sheromani Bajaj, Sherron C Crook, Shigeyuki Nishimura, Shintaro Nakano, Shirin Heydari, Shiv Kumar Choudhary, Shivali Patel, Shobana Ganesan, Shruti Pandey, Shuyang Zhang, Shweta Hande, Siddharth Gadage, Sik-Yin V Tan, Silvia Zottis Poletti, Silvia Riera, Silvia Valbuena, Simon Walsh, Simona Maspoli, Simone Savaris, Si-Ting Feng, So Yang Cho, Solomon Yakubov, Songlin Zhu, Songtao Wang, Sonia Guerrero, Sonika Gupta, Sonja Salinger Martinovic, Sonya Brons, Sorin Brener, Sothinathan Gurunathan, Souheil Saba, Soundarya Nayak, Sowjanya Reddy, Srinivasa Potluri, Sriram Sudarshan, Srun Kuanprasert, Stacie Van Oosterhout, Stamatios Lerakis, Stanley E Cobos, Stefan C Bertog, Stefan M Simović, Stefan Weikl, Stefano Di Marco, Stefano Provasoli, Stephanie A Tirado, Stephanie C Boer, Stephanie M Lane, Stephanie Ferket, Stephanie Kelly, Stephanie Wasmiller, Stephen H McKellar, Stephen P Hoole, Stephen Fremes, Stephen Preston, Steve Leung, Steven A Fein, Steven J Lindsay, Steven P Sedlis, Steven Giovannone, Steven Michael, Steven Weitz, Stijn van Vugt, Subhash Banerjee, Sudhir Naik, Suellen Hosino, Sukie Desire, Sukit Yamwong, Suku T Thambar, Sulagna Mookherjee, Suman Singh, Sundeep Mishra, Sunil Kumar Verma, Supap Kulthawong, Supatchara Khwakhong, Surendra Naik, Suresh Babu, Surin Woragidpoonpol, Suryaprakash Narayanappa, Susan Derbyshire, Susan Gent, Susan Mathus, Susan Milbrandt, Susan Moore, Susan Regan, Susan Stinson, Susan Webber, Susana Silva, Susanna Stevens, Susanne Gruensfelder, Suthara Aramcharoen, Suvarna Kolhe, Suzana Tavares, Suzanne Arnold, Suzanne Welsh, Svetlana Apostolovic, Swapna Kunhunny, Ta-Chuan Hung, Taissa Zappernick, Tali Sharir, Talita Silva, Tamara Colaiácovo Soares, Tapan Umesh Pillay, Tarun K Mittal, Tatiana Trifonova, Tauane Bello Duarte, Tauqir Huk, Téodora Dutoiu, Terrance Chua, Terry Weyand, Thabitha Charles, Theodoros Kofidis, Theresa McCreary, Thierry Lefevre, Thippeekaa Arumairajah, Thitipong Tepsuwan, Thomas J Mulhearn, Thomas M Meyer, Thomas P Rocco, Thomas R Downes, Thomas Crain, Thomas Haldis, Thomas Mathew, Thomas Redick, Thounaojam Indira Devi, Thuraia Nageh, Tia Cauthren, Tiago Silva, Tiffany Little, Tijana Andric, Tina Harding, Titus Lau, Tiziana Formisano, Tiziano Moccetti, Tomasz Ciurus, Tomasz Mazurek, Tomasz Tarchalski, Toshiyuki Nagai, Tri Tran, Tricia Youn, Trish Tucker, Trudie Milner, Tuhina Bose, Tushar Kotecha, Udo Sechtem, Uma S Valeti, Umberto Cucchini, Umesh Badami, Upendra Kaul, V K Bahl, V S Narain, Valentina Casali, Valeria Godoy, Valerie Robesyn, Vamshi P Priya, Vandana Yadav, Vera McKinney, Veronica De Lenges, Veronica Tinnirello, Vicente Miro, Victor Navarro, Victoria Gumerova, Victoria Hernandez, Vidya Seeratan, Vijay Kumar, Vikentiy Y Kozulin, Viktoria Bulkley, Vilmar Veiga Jr, Vincent Setang, C P Vineeth, Virginai Pubull Nuñez, Virginia Fernández-Figares, Vitor Gomes, Viviana Gabriel, Viviane Dos Santos, Viviane Almeida, Vlad A Iliescu, Vladan Mudrenovic, Vladimir Dzavik, Vojislav L Giga, Walter Enrique Mogrovejo, Wan Xian Chan, Wanda C Marfori, Wanda Parker, Warangkana Mekara, Wassim Nona, Wayne Old, Wayne Pennachi, Weerachai Nawarawong, Wei Chen, Wei Su, Weibing Xing, Wei-Ren Lan, Wenda Crawford, Wendy L Stewart, Wendy Drewes, Wenhua Lin, William B Abernethy, William D Salerno, William F Fearon, William Vergoni, William Weintraub, Winnie C Sia, Wlodzimierz J Musial, Xacobe Flores-Ríos, Xavier Garcia-Moll Marimon, Xi Su, Xiang Ma, Xiangqiong Gu, Xiao Wang, Xiaomei Li, Xiaowei Yao, Xin Fu, Xin Su, Xin Zeng, Xinchun Yang, Xiuhong Li, Xuehua Fang, Xutong Wang, Yaming Geng, Yan Yan, Yanek Pépin-Dubois, Yanfu Wang, Yang Wang, Yanmeng Tian, Yaping Huang, Yechen Han, Yesenia Zambrano, Yi-Hsuan Yang, Ying Tung Sia, Yining Yang, Yitong Ma, Yolayfi Peralta, Yongjian Wu, Yu Kunwu, Yu Zhao, Yudong Peng, Yueh-Hung Lin, Yulan Zhao, Yumei Dong, Yunhai Zhao, Yutthaphan Wannasopha, Yvonne Taul, Zakir Sahul, Zalina Kudzoeva, Zbigniew Kalarus, Zeljko Z Markovic, Zhen Huang, Zheng Ji, Zhenyu Liu, Zhou Yue, Zhulin Zhang, Zhuxi Li, Zile Singh Meharwal, Ziliang Bai, Zixiang Yu, Zohra Huda, Zoltan Davidovits, Maron D.J., Hochman J.S., Reynolds H.R., Bangalore S., O'Brien S.M., Boden W.E., Chaitman B.R., Senior R., Lopez-Sendon J., Alexander K.P., Lopes R.D., Shaw L.J., Berger J.S., Newman J.D., Sidhu M.S., Goodman S.G., Ruzyllo W., Gosselin G., Maggioni A.P., White H.D., Bhargava B., Min J.K., John Mancini G.B., Berman D.S., Picard M.H., Kwong R.Y., Ali Z.A., Mark D.B., Spertus J.A., Krishnan M.N., Elghamaz A., Moorthy N., Hueb W.A., Demkow M., Mavromatis K., Bockeria O., Peteiro J., Miller T.D., Szwed H., Doerr R., Keltai M., Selvanayagam J.B., Gabriel Steg P., Held C., Kohsaka S., Mavromichalis S., Kirby R., Jeffries N.O., Harrell F.E., Rockhold F.W., Broderick S., Bruce Ferguson T., Williams D.O., Harrington R.A., Stone G.W., Rosenberg Y, and ISCHEMIA Research Group: Joseph Ricci, A Tello Montoliu, A I Robero Aniorte, Abbey Mulder, Abhay A Laddu, Abhinav Goyal, Abhishek Dubey, Abhishek Goyal, Abigail Knighton, Abraham Oomman, Adam J Jaskowiak, Adam Kolodziej, Adam Witkowski, Adnan Hameed, Adriana Anesini, Afshan Hussain, Agne Juceviciene, Agne Urboniene, Agnes Jakal, Agnieszka Szramowska, Ahmad Khairuddin, Ahmed Abdel-Latif, Ahmed Adel, Ahmed Aljzeeri, Ahmed Kamal, Ahmed Talaat, Aimee Mann, Aira Contreras, Ajit Kumar, V K Kumar, Akemi Furukawa, Akshay Bagai, Akvile Smigelskaite, Alain Furber, Alain Rheault, Alaine Melanie Loehr, Alan Rosen, Albert Varga, Albertina Qelaj, Alberto Barioli, Aldo Russo, Alec Moorman, Alejandro Gisbert, Aleksandra Fratczak, Aleksandras Laucevicius, Alena Kuleshova, Alessandro Sionis, Alexander A Sirker, Alexander M Chernyavskiy, Alexandra Craft, Alexandra Vazquez, Alexandre Ciappina Hueb, Alexandre S Colafranseschi, Alexandre Schaan de Quadros, Alexandre Tognon, Ali Alghamdi, Alice Manica Muller, Aline Nogueira Rabaça, Aline Peixoto Deiro, Alison Hallam, Allegra Stone, Allison Schley, Almudena Castro, Alvaro Rabelo Ales, Amanda Germann, Amanda O'Malley, Amar Uxa, Amarachi Ojajuni, Amarino C Oliveira Jr, Amber B Hull, Ambuj Roy, Amer Zarka, Amir Janmohamed, Ammani Brown, Ammy Malinay, Amparo Martinez Monzonis, Amy J Richards, Amy Iskandrian, Amy Ollinger, Ana D Djordjevic-Dikic, Ana Fernández Martínez, Ana Gomes Almeida, Ana Paula Batista, Ana Rita Francisco, Ana S Mladenovic, Ana Santana, Anam Siddiqui, Anastasia M Kuzmina-Krutetskaya, Andras Vertes, Andre S Sousa, Andre Gabriel, André Schmidt, Andrea M Lundeen, Andrea Bartykowszki, Andrea Lorimer, Andrea Mortara, Andrea Pascual, Andreia Coelho, Andreia Rocha, Andrés García-Rincón, Andrew G Howarth, Andrew J Moriarty, Andrew Docherty, Andrew Starovoytov, Andrew Zurick, Andrzej Łabyk, Andrzej Swiatkowski, Andy Lam, Anelise Kawakami, Angela Hoye, Angela Kim, Angelique Smit, Angelo Nobre, Anil V Shah, Anja Ljubez, Anjali Anand, Ankush Sachdeva, Ann Greenberg, Ann Luyten, Ann Ostrander, Anna Di Donato, Anna Cichocka-Radwan, Anna Fojt, Anna Plachcinska, Anna Proietti, Anna Teresinska, Anne Marie Webb, Anne Cartwright, Anne Heath, Anne Mackin, Anong Amaritakomol, Anong Chaiyasri, Anoop Chauhan, Anoop Mathew, Anthony Gemignani, Anto Luigi Andres, Antonia Vega, Antonietta Hansen, Antonino Ginel Iglesias, Antonio Carlos Carvalho, Antonio Di Chiara, Antonio Serra Peñaranda, Antonio Carvalho, Antonio Colombo, Antonio Fiarresga, Anupama Rao, Aquiles Valdespino-Estrada, Araceli Boan, Areef Ishani, Ariel Diaz, Arijit Ghosh, Arintaya Prommintikul, Arline Roberts, Arnold H Seto, Arnold P Good, Arshed Quyyumi, Arthur J Labovitz, Arthur Kerner, Arturo S Campos-Santaolalla, Arunima Misra, Ashok Mukherjee, Ashok Seth, Ashraf Seedhom, Asim N Cheema, Asker Ahmed, Atul Mathur, Atul Verma, Audrey W Leong, Axel Åkerblom, Axelle Fuentes, Aynun Naher, Badhma Valaiyapathi, Baljeet Kaur, Bandula Guruge, Barbara Brzezińska, Barbara Nardi, Bartosz Czarniak, Bebek Singh, Begoña Igual, Bela Merkely, Belen Cid Alvarez, Benjamin J Spooner, Benjamin J W Chow, Benjamin Cheong, Benoy N Shah, Bernard de Bruyne, Bernardas Valecka, Bernhard Jäger, Beth A Archer, Beth Abramson, Beth Jorgenson, Bethany Harvey, Betsy O'Neal, Bev Atkinson, Bev Bozek, Bevin Lang, Bijulal Sasidharan, Bin Yang, Bin Zhang, Binoy Mannekkattukudy Kurian, Bjoern Goebel, Bob Hu, Bogdan A Popescu, Bogdan Crnokrak, Bolin Zhu, Bonnie J Kirby, Brandi D Zimbelman, Brandy Starks, Branko D Beleslin, Brenda Hart, Brian P Shapiro, Brian McCandless, Brianna Wisniewski, Brigham R Smith, Brooks Mirrer, Bruce McManus, Bruce Rutkin, Bruna Edilena Paulino, Bruna Maria Ascoli, Bryn Smith, Byron J Allen, C Michael Gibson, C Noel Bairey Merz, Calin Pop, Cameron Hague, Camila Thais de Ormundo, Candace Gopaul, Candice P Edillo, Carísi A Polanczyk, Carita Krannila, Carla Vicente, Carl-Éric Gagné, Carlo Briguori, Carlos Peña Gil, Carlos Alvarez, Carly Ohmart, Carmen C Beladan, Carmen Ginghina, Carol M Kartje, Caroline Alsweiler, Caroline Brown, Caroline Callison, Caroline Pinheiro, Caroline Rodgers, Caroline Spindler, Carolyn Corbett, Carrie Drum, Casey Riedberger, Catherine Bone, Catherine Fleming, Catherine Gordon, Catherine Jahrsdorfer, Catherine Lemay, Catherine Weick, Cathrine Patten, Cecilia Goletto, Cezary Kepka, Chandini Suvarna, Chang Xu, Chantale Mercure, Charle A Viljoen, Charlene Wiyarand, Charles Jia-Yin Hou, Charles Y Lui, Charles Cannan, Charles Cornet, Charlotte Pirro, Chataroon Rimsukcharoenchai, Chen Wang, Cheng-Ting Tsai, Chen-Yen Chien, Cheryl A Allardyce, Chester M Hedgepeth, Chetan Patel, Chiara Attanasio, Chih-Hsuan Yen, Chi-Ming Chow, Ching Min Er, Ching-Ching Ong, Cholenahally Nanjappa Manjunath, Chris Beck, Chris Buller, Christel Vassaliere, Christian Hamm, Christiano Caldeira, Christie Ballantyne, Christina Björklund, Christine R Hinton, Christine Bergeron, Christine Masson, Christine Roraff, Christine Shelley, Christophe Laure, Christophe Thuaire, Christopher Kinsey, Christopher McFarren, Christopher Spizzieri, Christopher Travill, Chun-Chieh Liu, Chung-Lieh Hung, Chunguang Li, Chun-Ho Yun, Chunli Xia, Ciarra Heard, Cidney Schultz, Clare Venn-Edmonds, Claudia P Hochberg, Claudia Wegmayr, Claudia Cortés, Claudia Escobar, Cláudia Freixo, Claudio T Mesquita, Clemens T Kadalie, Colin Berry, Constance Philander, Corine Thobois, Costantino Costantini, Courtney Page, Craig Atkinson, Craig Barr, Craig Paterson, Cristina Bare, Cynthia Baumann, Cynthia Burman, Dalisa Espinosa, Damien Collison, Dan Deleanu, Dan Elian, Dan Gao, Dana Oliver, Daniel P Vezina, Daniel O'Rourke, Daniele Komar, Danielle Schade, Darrel P Francis, Dastan Malaev, David A Bull, David E Winchester, David P Faxon, David Booth, David Cohen, David DeMets, David Foo, David Schlichting, David Taggart, David Waters, David Wohns, Davis Vo, Dawid Teodorczyk, Dawn Shelstad, Dawn Turnbull, Dayuan Li, Dean Kereiakes, Deborah O'Neill, Deborah Yip, Debra K Johnson, Debra Dees, Deepak L Bhatt, Deepika Gopal, Deepti Kumar, Deirdre Mattina, Deirdre Murphy, Delano R Small, Delsa K Rose, Dengke Jiang, Denis Carl Phaneuf, Denise Braganza, Denise Fine, Derek Cyr, Desiree Tobin, Diana Cukali, Diana Parra, Diane Camara, Diane Minshall Liu, Diego Adrián Vences, Diego Franca de Cunha, Dimitrios Stournaras, Dipti Patel, Dongze Li, Donna Exley, Dorit Grahl, Dragana Stanojevic, Duarte Cacela, Dwayne S G Conway, E Pinar Bermudez, Eapen Punnoose, Edgar L Tay, Edgar Karanjah, Edoardo Verna, Eduardo Hernandez-Rangel, Edward D Nicol, Edward O McFalls, Edward T Martin, Edyta Kaczmarska, Ekaterina I Lubinskaya, Elena A Demchenko, Elena Refoyo Salicio, Eli Feen, Elihú Durán-Cortés, Elisabeth M Janzen, Elise L Hannemann, Elise van Dongen, Elissa Restelli Piloto, Eliza Kaplan, Elizabeta Srbinovska Kostovska, Elizabeth Capasso-Gulve, Elizabeth Congdon, Elizabeth Ferguson, Elizaveta V Zbyshevskaya, Ellen Magedanz, Ellie Fridell, Ellis W Lader, Elvin Kedhi, Emanuela Racca, Emilie Tachot, Emily DeRosa, Encarnación Alonso-Álvarez, Eric Nicollet, Eric Peterson, Erick Alexánderson Rosas, Erick Donato Morales, Erin Orvis, Ermina Moga, Estelle Montpetit, Estevao Figueiredo, Eugene Passamani, Eugenia Nikolsky, Eunice Yeoh, Evgeniy I Kretov, Ewa Szczerba, Ewelina Wojtala, Expedito Eustáquio Ribeiro Silva, F Marin Ortuño, Fabio R Farias, Fabio Fimiani, Fabrizio Rolfo, Fa-Chang Yu, Fadi Hage, Fadi Matar, Fahim Haider Jafary, Fang Feng, Fang Liu, Fatima Ranjbaran, Fatima Rodriguez, Fausto J Pinto, Fauzia Rashid, Federica Ramani, Fei Wang, Fernanda Igansi, Filipa Silva, Filippo Ottani, Fiona Haines, Firas Al Solaiman, Flávia Egydio, Flavio Lyra, Florian Egger, Fran Farquharson, Frances Laube, Francesc Carreras Costa, Francesca de Micco, Francesca Bianchini, Francesca Pezzetta, Francesca Pietrucci, Francesco Orso, Francesco Pisano, Francis Burt, Francisca Patuleia Figueiras, Francisco Fernandez-Aviles, Francois Pierre Mongeon, Frans Van de Werf, Franziska Guenther, Fraser N Witherow, Fred Mohr, Frederico Dall'Orto, Fumiyuki Otsuka, G De La Morena, G Karthikeyan, Gabor Dekany, Gabor Kerecsen, Gabriel Galeote, Gabriel Grossmann, Gabriel Vorobiof, Gabriela Sanchez de Souza, Gabriela Guzman, Gabriela Zeballos, Gabriele Gabrielli, Gabriele Jakl-Kotauschek, Gail A Shammas, Gail Brandt, Gang Chen, Gary E Lane, Gary J Luckasen, Gautam Sharma, Gelmina Mikolaitiene, Gennie Yee, Georg Nickenig, George E Revtyak, George J Juang, Gerald Fletcher, Gerald Leonard, Gerard Patrick Devlin, Gerard Esposito, Gergely Ágoston, Gervasio Lamas, Geza Fontos, Ghada Mikhail, Gia Cobb, Gian Piero Perna, Gianpiero Leone, Giles Roditi, Gilles Barone-Rochette, Girish Mishra, Giuseppe Tarantini, Glenda Wong, Glenn S Hamroff, Glenn Rayos, Gong Cheng, Gonzalo Barge-Caballero, Goran Davidović, Goran Stankovic, Gordana Stevanovic, Grace Jingyan Wang, Grace M Young, Graceanne Wayser, Graciela Scaro, Graham S Hillis, Graham Wong, Grazyna Anna Szulczyk, Gregor Simonis, Gregory Kumkumian, Gretchen Ann Peichel, Grzegorz Gajos, Gudrun Steinmaurer, Guilherme G Rucatti, Guilherme Portugal, Guilhermina Cantinho Lopes, Guillem Pons Lladó, Gunnar Frostfelt, Gurpreet S Wander, Gurpreet Gulati, Gustavo Pucci, Hafidz Abd Hadi, Haibo Zhang, Haitao Wang, Halina Marciniak, Han Chen, Hanan Kerr, Hani Najm, Hanna Douglas, Hannah Phillips, Hao Dai, Haojian Dong, Haqeel Jamil, Harikrishnan Sivadasanpillai, Harry Suryapranata, Hassan Reda, Hayley Pomeroy, Heather Barrentine, Heather Golden, Heather Hurlburt, Heidi Wilson, Helen C Tucker, Helene Abergel, Hemalata Siddaram, Hermine Osseni, Herwig Schuchlenz, Hesong Zeng, Hicham Skali, Hilda Solomon, Hollie Horton, Holly Hetrick, Holly Little, Holly Park, Hongjie Chi, Hossam Mahrous, Howard A Levite, Hristo Pejkov, Huajun Li, Hugo Bloise-Adames, Hugo Marques, Hui Zhong, Hui-Min Zhang, Humayrah Hashim, Hung-I Yeh, Hussien El Fishawy, Ian Webb, Iftikhar Kullo, Igor O Grazhdankin, Ihab Hamzeh, Ikraam Hassan, Ikuko Ueda, Ileana L Pina, Ilona Tamasauskiene, Ilse Bouwhuis, Imran Arif, Ina Wenzelburger, Inês Zimbarra Cabrita, Ines Rodrigues, Inga H Robbins, Inga Soveri, Ingela Schnittger, Iqbal Karimullah, Ira M Dauber, Iram Rehman, Irena Peovska Mitevska, Irene Marthe Lang, Irina Subbotina, Irma Kalibataite-Rutkauskiene, Irni Yusnida, Isabel Estela Carvajal, Isabella C Palazzo, Isabelle Hogan, Isabelle Roy, Ishba Syed, Ishita Tejani, Ivan A Naryshkin, Ivana Jankovic, Iwona Niedzwiecka, J David Knight, Jacek Kusmierek, Jackie M White, Jackie Chow, Jacob Udell, Jacqueline E Tamis-Holland, Jacqueline Fannon, Jacquelyn A Quin, Jacquelyn Do, Jaekyeong Heo, Jakub Maksym, James E Davies, James H O'Keefe Jr, James J Jang, James Cha, James Harrison, James Hirsch, James Stafford, James Tatoulis, Jamie Rankin, Jan Henzel, Jan Orga, Jana Tancredi, Janaina Oliveira, Jane Burton, Jane Eckstein, Jane Marucci, Janet P Knight, Janet Blount, Janet Halliday, Janetta Kourzenkova, Janitha Raj, Jan-Malte Sinning, Jaqueline Pozzibon, Jaroslaw Drozdz, Jaroslaw Karwowski, Jason D Glover, Jason Loh Kwok, Jason T Call, Jason Linefsky, Jassira Gomes, Jati Anumpa, Javier J Garcia, Javier Courtis, Jay Meisner, K Jayakumar, Jayne Scales, Jean E Denaro, Jean Michel Juliard, Jean Ho, Jeanette K Stansborough, Jean-Michel Juliard, Jeanne Russo, Jeannette J M Schoep, Jeet Thambyrajah, Jeff Leimberger, Jeffery A Breall, Jeffrey A Kohn, Jeffrey C Milliken, Jeffrey Anderson, Jeffrey Blume, Jeffrey Kanters, Jeffrey Lorin, Jeffrey Moses, Jelena J Stepanovic, Jelena Celutkiene, Jelena Djokic, Jelena Stojkovic, Jenne M Jose, Jenne Manchery, Jennifer A Mull, Jennifer H Czerniak, Jennifer L Stanford, Jennifer Gillis, Jennifer Horst, Jennifer Isaacs, Jennifer Langdon, Jennifer Thomson, Jennifer Tomfohr, Jennifer White, Jen-Yuan Kuo, Jeremy Rautureau, Jerome Fleg, Jessica Berg, Jessica Rodriguez, Jessica Waldron, Jhina Patro, Jia Li, Jiajia Mao, Jiamin Liu, Jian'an Wang, Jianhua Li, Jianxin Zhang, Jie Qi, Jihyun Lyo, Jill Marcus, Jim Blankenship, Jing Zhang, Jingjing Liu, Jing-Yao Fan, Jiun-Yi Li, Jiwan Pradhan, Jiyan Chen, J M Rivera Caravaca, Jo Evans, Joan Garcia Picart, Joan Hecht, Joanna Jaroch, Joanna Zalewska, Joanne Kelly, Joanne Taaffe, João Reynaldo Abbud, João V Vitola, Joaquín V Peñafiel, Jocelyne Benatar, Jody Bindeman, Joe Sabik, Joel Klitch, Johann Christopher, Johannes Aspberg, John D Friedman, John F Beltrame, John F Heitner, John Joseph Graham, John R Davies, John Doan, John Kotter, John Kurian, John Mukai, John Pownall, Jolanta Sobolewska, Jon Kobashigawa, Jonathan L Goldberg, Jonathan W Bazeley, Jonathan Byrne, Jonathan Himmelfarb, Jonathan Leipsic, Jonean Thorsen, Jorge F Trejo Gutierrez, Jorge Escobedo, Jorik Timmer, José A Ortega-Ramírez, José Antonio Marin-Neto, Jose D Salas, Jose Enrique Castillo, Jose Francisco Saraiva, José J Cuenca-Castillo, Jose L Diez, José Luis Narro Villanueva, José Luiz da Vieira, José M Flores-Palacios, Jose Ramon Gonzalez, Jose Seijas Amigo, Jose Fragata, Josep Maria Padró, Josheph F X McGarvey Jr, Joseph Hannan, Joseph Sacco, Joseph Sweeny, Joseph Wiesel, Josephine D Abraham, Joshua P Loh, Joy Burkhardt, Joyce R White, Joyce Riestenberg-Smith, Judit Sebo, Judith L Meadows, Judith Wright, Judy Mae Foltz, Judy Hung, Judy Otis, Juergen Stumpf, Jui-Peng Tsai, Julia S Dionne, Julia de Aveiro Morata, Julie Bunke, Julie Morrow, Julio César Figal, Jun Fujita, Jun Jiang, Junhua Li, Junqing Yang, Juntima Euathrongchit, Jyotsna Garg, K Manjula Rani, K Preethi, Kaatje Goetschalckx, Kai Eggers, Kamalakar Surineni, Kanae Hirase, T R Kapilamoorthy, Karen Calfas, Karen Gratrix, Karen Hallett, Karen Hultberg, Karen Nugent, Karen Petrosyan, Karen Swan, Karolina Kryczka, Karolina Wojtczak-Soska, Karolina Wojtera, Karsten Lenk, Karthik Ramasamy, Katarzyna Łuczak, Katarzyna Malinowska, Kate Pointon, Kate Robb, Katherine Martin, Kathleen Claes, Kathryn Carruthers, Kathy E Siegel, Katia Drouin, Katie Fowler-Lehman, Kavita Rawat, Kay Rowe, Keiichi Fukuda, Keith A A Fox, Ken Mahaffey, Kendra Unterbrink, Kenneth Giedd, Kerrie Van Loo, Kerry Lee, Kerstin Bonin, Kevin R Bainey, Kevin T Harley, Kevin Anstrom, Kevin Chan, Kevin Croce, Kevin Landolfo, Kevin Marzo, Keyur Patel, Khaled Abdul-Nour, Khaled Alfakih, Khaled Dajani, Khaled Ziada, Khaula Baloch, Khrystyna Kushniriuk, Kian-Keong Poh, Kim F Ireland, Kim Holland, Kimberly Ann Byrne, Kimberly E Halverson, Kimberly Elmore, Kimberly Miller-Cox, Kiran Reddy, Kirsten J Quiles, Kirsty Abercrombie, Klaus Matschke, Konrad Szymczyk, Koo Hui Chan, Kotiboinna Preethi, Kozhaya Sokhon, Krissada Meemuk, Kristian Thygesen, Kristin M Salmi, Kristin Newby, Kristina Wippler, Kristine Arges, Kristine Teoh, Krystal Etherington, Krystyna Łoboz-Grudzień, Krzysztof W Reczuch, Krzysztof Bury, Krzysztof Drzymalski, Krzysztof Kukuła, Kuo-Tzu Sung, Kurt Huber, Ladda Douangvila, Lance Sullenberger, Larissa Miranda Trama, Laszlone Matics, Laura Drew, Laura Flint, Laura Keinaite, Laura Sarti, Laurel Kolakaluri, Lawrence M Phillips, Lawrence Friedman, Lawrence Phillips, Lazar Velicki, Leah Howell, Leandro C Maranan, Leanne Cox, Ledjalem Daba, Lei Zhang, Lekshmi Dharmarajan, Leo Bockeria, Leonardo Pizzol Caetano, Leonardo Bridi, Leonid L Bershtein, Leszek Sokalski, Li Hai Yan, Li Li, Lia Nijmeijer, Lidia Sousa, Lihong Xu, Lihua Zhang, Lili Zhang, Lilia Schiavi, Lilian Mazza Barbosa, Lillian L Khor, Lina Felix-Stern, Linda L Hall, Linda M Hollenweger, Linda Arcand, Linda Davidson-Ray, Linda Schwarz, Lindsey N Sikora, Lingping Chi, Lino Patricio, Liping Zhang, Lisa Chaytor, Lisa Hatch, Lisa McCloy, Lisa Wong, Liselotte Persson, Lixin Jiang, Liz Low, Ljiljana Pupic, Loïc Bière, Lorenzo Monti, Lori Christensen, Lori Pritchard, Loriane Black, Lori-Ann Desimone, Lori-Ann Larmand, Lorraine McGregor, Louise Morby, Louise Thomson, Luc Harvey, Luciana de Pádua Baptista, Lucilla Garcia, Ludivine Eliahou, Ludmila Helmer, Luis F Smidt, Luis Bernanrdes, Luis Guzman, Luiz A Carvalho, Luyang Xiong, Lynette L Teo, Lynn M Neeson, Lynne Winstanley, M Barbara Srichai-Parsia, M Quintana Giner, M Sowjanya Reddy, M Valdés Chávarri, M Grazia Rossi, Maarten Simoons, Maayan Konigstein, Maciej Lesiak, Maciej Olsowka, Mafalda Selas, Magalie Corfias, Magdalena Madero Rovalo, Magdalena Łanocha, Magdalena Miller, Magdalena Misztal-Teodorczyk, Magdalena Rantinella, Magdy Abdelhamid, Magnolia Jimenez, Mahboob Alam, Mahevamma Mylarappa, Mahfouz El Shahawy, Mahmoud Mohamed, Mahmud Al-Bustami, Majo X Joseph, Malgorzata Frach, Małgorzta Celińska-Spodar, Malte Helm, Manas Chacko, Mandy Murphy, Manitha Vinod, Manjula Rani, Manu Dhawan, Manuela Mombelli, Marcel Weber, Marcello Galvani, Marcelo Jamus Rodrigues, Marcia F Dubin, Marcia F Werner Bayer, Marcin Szkopiak, Marco Antonio Monsalve, Marco Bizzaro Santos, Marco Magnoni, Marco Marini, Marco Sicuro, Marco Zenati, Marcos Valério Coimbra Resende, Marek Roik, Margalit Bentzvi, Margaret Gilsenan, Margaret Iraola, Margot C Quinn, Maria A Alfonso, Maria Antonieta Pereira Moraes, María Dolores Martínez-Ruíz, María Fernanda Canales, Maria Inês Caetano, Maria P Corral, Maria Pérez García, Maria Victoria Actis, Maria Aguirre, Maria Andreasson, Maria Aprile, Maria Colton, Maria Eugenia Martin, Maria Lasala, Maria Lorenzo, Maria Posada, Maria Shier, Maria Thottam, Mariana V Furtado, Mariana Yumi Okada, Marianna D A Dracoulakis, Marianne De Andrade, Mariano Rubio, Marie Essermark, Marielle Scherrer-Crosbie, Marija T Petrovic, Marija Zdravkovic, Marilyn Black, Marina Garcia, Mario J Garcia, Mariola Szulik, Marisa Orgera, Mark A de Belder, Mark Harbinson, Mark Hyun, Mark Peterson, Mark Xavier, Marlowe Mosley, Marta Capinha, Marta Marcinkiewicz-Siemion, Marta Swiderek, Martha Meyer, Martina Ceseri, Martina Tricoli, Marvin Kronenberg, Mary Williams, Mary Ann Champagne, Mary Colleen Rogge, Mary R Soltau, Mary Streif, Massimo Villella, Massoud Leesar, Matei Claudia, Mateusz Solecki, Matías Nicolás Mungo, Matthew Wall Jr, Matthew Budoff, Matthew Jezior, Matthew Luckie, Matthias Friedrich, Mauren P Haeffner, Maximilian Tscharre, Max-Paul Winter, Mayana Almeida, Mayil S Krishnam, Mayuri Patel, Meenakshi Mishra, Megan Manocchia, Meghana Kakade, Melanie J Munro, Melissa D Chaplin, Melissa LeFevre, Mervyn Andiapen, Michael A Gibson, Michael B Rubens, Michael C Turner, Michael D Shapiro, Michael W Lee, Michael Berlowitz, Michael Davidson, Michael Mack, Michael McDaniel, Michael Mumma, Michal Wlodarczyk, Michel G Khouri, Michel S Slama, Michele Rawlins, Michelle M Bonner, Michelle M Seib, Michelle Chang, Michelle Crowder, Michelle Dixon, Michelle Mayon, Michelle McEvoy, Michelle Yee, Miguel M Fernandes, Miguel Nobre Menezes, Miguel Souto Bayarri, Miguel Barrero, Mikhail T Torosoff, Milan R Dobric, Milan Dobric, Milica Nikola Dekleva, Milind Avdhoot Gadkari, Millie Gomez, Min Tun Kyaw, Miriam Brooks, Miroslav Stevo Martinovic, Mitchel B Lustre, Mohammad Tariq Vakani, Mohammad El-Hajjar, Mohammed Al-Amoodi, Mohammed Hussain, Mohammed Saleem, Moisés Blanco-Calvo, Moisés Jiménez-Santos, Mona Bhatia, Monica Rosca, Monika Laukyte, Montserrat Gracida Blanca, Montserrat Vila Perales, Mouaz H Al-Mallah, Moysés de Oliveira Filho, Mpiko Ntsekhe, Muhamed Saric, Mulei Chen, Myriam Brousseau, Myrthes Emy Takiuti, Nada Cemerlic-Adjic, Nadia Asif, Nadia Gakou, Nafisa Hussain, Nana O Katamadze, Nancy L Clapp, Nancy Aedy, Nandita Nataraj, Nanette K Wenger, Naomi Uchida, Nasrul Ismail, Natalia S Oliveira, Natalia de Carvalho Maffei, Natalie Spitzer, Natasha C Putnam, Naved Aslam, Neamat Mowafy, Neeraj Pandit, Neeraj Parakh, Nevena Garcevic, Ngaire Meadows, Nhi N Tran, Nicholas Danchin, Nicki Lakeman, Nicola Johnston, Nicolas W Shammas, Nicole Saint Vrestil, Nicole Deming, Nier Zhong, Niket Patel, Nikola N Boskovic, Nikolaos Karogiannis, Nikos Werner, Nina Johnston, Ning Zhang, Ning Zhou, Niree Hindoyan, Nirmal Kumar, Nitika Chadha, Nitish Naik, Nodira Aripova, Noloyiso Mtana, Nona A Eskelson, Noor Syamira Mokhtar, Noppon Taksaudom, Nor Asiah Basri, Nora Marchelletta, Norma Hogg, Nungshi Jungla, Nuno Ferreira, Oksana A Lubyanaya, Olga B Nikolaeva, Olga Cañavate, Olga Sobrino, Olga Walesiak, Olga Walter, Olga Zdończyk, Olivia J Lim, Olivia Anaya, Olivia Mancilla, Olivier Dubourg, Olugbenga Bello, Omar Almousalli, Omar Thompson, Oni Olurinde, Or Harel, Osama Raheem, Oscar Méndiz, Óscar Prada-Delgado, Oz Shapira, P Christian Schulze, Pachara Panpunuan, Pal Maurovich-Horvat, Pallav Garg, Paloma Moraga, Pam Singh, Pamela Julian, Pamela Ouyang, Pamela Sigel, Pamela Woodard, Panpan Zhou, Paola Emanuela Poggio, Paola Smanio, Paolo Calabro, Paramjit Jeetley, Pascal Goube, Patricia K Nguyen, Patricia Alarie, Patricia Arakelian, Patricia Arsenault, Patricia Blaise, Patricia Brito, Patricia Cowper, Patricia Endsley, Patricia Mieses, Patrick B Alexander, Patrick Donnelly, Patrick Wilmot, Patrycja Lebioda, Paul C Gordon, Paul Der Mesropian, Paul Galiwango, Paul Hauptman, Paul Kennedy, Paula Beardsley, Paula García-González, Paulo Cury Rezende, Paulo Ricardo Caramori, Pavel S Kozlov, Pedro Canas Silva, Pedro Gabriel Melo Barros E Silva, Pedro Píccaro de Oliveira, Pedro Carvalho, Pedro Modas, Pedro Rio, Peeyush Jain, Peiyu He, Peter A McCullough, Peter H Stone, Peter M Pollak, Peter Douglass, Peter Henriksen, Peter OKane, Peter Ong, Philip Jones, Philip Rogal, Philippe Généreux, Philippe Menasche, Philippe Rheault, Phoebe Goold, Pierre Gervais, Pierre Michaud, Pilar Calvillo, Ping Chai, Piotr Jakubowski, Piotr Pruszczyk, Piotr Slomka, Piyamitr Sritara, Poay-Huan Loh, Poonam Sonawane, Pouneh Samadi, Pragnesh P Parikh, Prakash Deedwania, Pranav M Patel, Praneeth Polamuri, Pratiksha Sharma, Precilia Vasquez, Preeti Kamath, Prince Thomas, Priyadarshani Arambam, Puja K Mehta, Purvez Grant, Pushpa Naik, Qi Zhong, Qian Zhao, Qiang Zhou, Qianqian Yuan, Qin Yu, Qingxian Li, Qiulan Xie, Qiutang Zeng, R J Vindhya, R James Gerlach, Rachel King, Rada Vučić, Radmila Lyubarova, Radoslaw Pracon, Raewyn Fisher, Rafael Beyar, Rafael Diaz, Rafael Selgas, Raffaele Bugiardini, Raffaele Fanelli, Raisa Kavalakkat, V S Rajalekshmi, Rajat S Barua, Rajeev Menon, Rajesh Gopalan Nair, Rajesh Francis, Rajiv Narang, Rakesh Yadav, Ralph Alan Huston, T Ramakrishnan, Ramesh de Silva, Rami El Mahmoud, Ramiro Carvalho, Ramon de Jesús-Pérez, Ramona Stevens, Ran Leng, Ranjan Kachru, Ranjit Kumar Nath, Raquel Sanchez, Raven R Dwyer, Raven Lee, Ray Wyman, Raymond C Wong, Raymond W Little, Raymundo Ocaranza Sanchez, Rebecca J Wimmer, Rebecca Bariciano, Rebecca Otis, Rebekah R Herrmann, Reem Yunis, Reinette Hampson, Renato Abdala Karam, Renee C Hessian, Renee Kaneshiro, Reshma Ravindran, Reto Andreas Gamma, Reyna Bhandari, Reza Arsanjani, Ricardo L Lopes, Ricardo Mendes Oliveira, Ricardo Costa, Richa Bhatt, Richard F Davies, Richard H J Trimlett, Richard Goldweit, Rik Hermanides, Rine Nakanishi, Rinu R Sidh, Risha Patel, Rita Coram, Rizwan A Siddiqui, Rob S Beanlands, Robert J Hamburger, Robert K Riezebos, Robert M Donnino, Robert Bojar, Robert Chilton, Robert Guyton, Robert Henderson, Robert Kornberg, Robert Leber, Robert Mao, Robert Stenberg, Roberta P Santos, Roberto René Favaloro, Roberto Amati, Rodolfo G S D Lima, Rodrigo J Cerci, Rogerio Tumelero, Rohit Tandon, Roma Tewari, Romalisa Miranda-Peats, Ron Wald, Ronald A Mastouri, Ronald G Morford, Ronald G Schwartz, Ronald P Pedalino, Rongrong Hu, Ronnell A Hansen, Ronny A Cohen, Rory Hachamovitch, Rosa Homem, Rosa Sandonato, Rosane Laimer, Rosann Gans, Roxanne Yost, Roy Mathew, Rubén Baleón-Espinosa, Ruben Ramos, Rubine Gevorgyan, Rui Ferreira, Rui Jing, Ruth Pérez-Fernández, S K Dwivedi, S Ramakrishnan, Saadat Khan, Sabahat Bokhari, Sabu Thomas, Sadath Lubna, Sajeeda Parveen Khan, Sajeev Chakanalil Govindan, Saket Girotra, Saleem Kassam, Sallie Canada, Salvador Cruz-Flores, Samaa Mohamed, Samantha Ly, Sameh El Kaffas, Samia Massalha, Sampoornima Setty, Samuel Nwosu, Sandeep Seth, Sandeep Singh, Sander R Niehe, Sandra M Rivest, Sandra S Zier, Sandra Ahoud, Sandy Carr, Sanjay Ganapathi, Sanjay Shetty, Sanjeev Sharma, Santa Jimenez, Santhosh Satheesh, Santiago A Garcia, Sara Fernandez, Sara Karlsson, Sara Salkind, Sara Temiyasathit, Sarah Medina Rodriguez, Sarah Beaudry, Sarah Hadjih, Sarah Williams, Sarah Zahrani, Sarju Ralhan, Sasa Hinic, Sasko Kedev, Satinder Singh, Satoshi Yasuda, Satvic Cholenahally Manjunath, Sau Lee, Scott M Kaczkowski, Scott Kinlay, Sean W Hayes, Sebastian Sobczak, Senait Asier, Sergey A Sayganov, Seth I Sokol, Shaheen Pandie, Shaiful Azmi Yahaya, Shamir Mehta, Shao-Ping Nie, Sharad Chandra, Sharder Islam, Sharon Tai, Sheetal Rupesh Karwa, Sheri Ussery, Sheromani Bajaj, Sherron C Crook, Shigeyuki Nishimura, Shintaro Nakano, Shirin Heydari, Shiv Kumar Choudhary, Shivali Patel, Shobana Ganesan, Shruti Pandey, Shuyang Zhang, Shweta Hande, Siddharth Gadage, Sik-Yin V Tan, Silvia Zottis Poletti, Silvia Riera, Silvia Valbuena, Simon Walsh, Simona Maspoli, Simone Savaris, Si-Ting Feng, So Yang Cho, Solomon Yakubov, Songlin Zhu, Songtao Wang, Sonia Guerrero, Sonika Gupta, Sonja Salinger Martinovic, Sonya Brons, Sorin Brener, Sothinathan Gurunathan, Souheil Saba, Soundarya Nayak, Sowjanya Reddy, Srinivasa Potluri, Sriram Sudarshan, Srun Kuanprasert, Stacie Van Oosterhout, Stamatios Lerakis, Stanley E Cobos, Stefan C Bertog, Stefan M Simović, Stefan Weikl, Stefano Di Marco, Stefano Provasoli, Stephanie A Tirado, Stephanie C Boer, Stephanie M Lane, Stephanie Ferket, Stephanie Kelly, Stephanie Wasmiller, Stephen H McKellar, Stephen P Hoole, Stephen Fremes, Stephen Preston, Steve Leung, Steven A Fein, Steven J Lindsay, Steven P Sedlis, Steven Giovannone, Steven Michael, Steven Weitz, Stijn van Vugt, Subhash Banerjee, Sudhir Naik, Suellen Hosino, Sukie Desire, Sukit Yamwong, Suku T Thambar, Sulagna Mookherjee, Suman Singh, Sundeep Mishra, Sunil Kumar Verma, Supap Kulthawong, Supatchara Khwakhong, Surendra Naik, Suresh Babu, Surin Woragidpoonpol, Suryaprakash Narayanappa, Susan Derbyshire, Susan Gent, Susan Mathus, Susan Milbrandt, Susan Moore, Susan Regan, Susan Stinson, Susan Webber, Susana Silva, Susanna Stevens, Susanne Gruensfelder, Suthara Aramcharoen, Suvarna Kolhe, Suzana Tavares, Suzanne Arnold, Suzanne Welsh, Svetlana Apostolovic, Swapna Kunhunny, Ta-Chuan Hung, Taissa Zappernick, Tali Sharir, Talita Silva, Tamara Colaiácovo Soares, Tapan Umesh Pillay, Tarun K Mittal, Tatiana Trifonova, Tauane Bello Duarte, Tauqir Huk, Téodora Dutoiu, Terrance Chua, Terry Weyand, Thabitha Charles, Theodoros Kofidis, Theresa McCreary, Thierry Lefevre, Thippeekaa Arumairajah, Thitipong Tepsuwan, Thomas J Mulhearn, Thomas M Meyer, Thomas P Rocco, Thomas R Downes, Thomas Crain, Thomas Haldis, Thomas Mathew, Thomas Redick, Thounaojam Indira Devi, Thuraia Nageh, Tia Cauthren, Tiago Silva, Tiffany Little, Tijana Andric, Tina Harding, Titus Lau, Tiziana Formisano, Tiziano Moccetti, Tomasz Ciurus, Tomasz Mazurek, Tomasz Tarchalski, Toshiyuki Nagai, Tri Tran, Tricia Youn, Trish Tucker, Trudie Milner, Tuhina Bose, Tushar Kotecha, Udo Sechtem, Uma S Valeti, Umberto Cucchini, Umesh Badami, Upendra Kaul, V K Bahl, V S Narain, Valentina Casali, Valeria Godoy, Valerie Robesyn, Vamshi P Priya, Vandana Yadav, Vera McKinney, Veronica De Lenges, Veronica Tinnirello, Vicente Miro, Victor Navarro, Victoria Gumerova, Victoria Hernandez, Vidya Seeratan, Vijay Kumar, Vikentiy Y Kozulin, Viktoria Bulkley, Vilmar Veiga Jr, Vincent Setang, C P Vineeth, Virginai Pubull Nuñez, Virginia Fernández-Figares, Vitor Gomes, Viviana Gabriel, Viviane Dos Santos, Viviane Almeida, Vlad A Iliescu, Vladan Mudrenovic, Vladimir Dzavik, Vojislav L Giga, Walter Enrique Mogrovejo, Wan Xian Chan, Wanda C Marfori, Wanda Parker, Warangkana Mekara, Wassim Nona, Wayne Old, Wayne Pennachi, Weerachai Nawarawong, Wei Chen, Wei Su, Weibing Xing, Wei-Ren Lan, Wenda Crawford, Wendy L Stewart, Wendy Drewes, Wenhua Lin, William B Abernethy, William D Salerno, William F Fearon, William Vergoni, William Weintraub, Winnie C Sia, Wlodzimierz J Musial, Xacobe Flores-Ríos, Xavier Garcia-Moll Marimon, Xi Su, Xiang Ma, Xiangqiong Gu, Xiao Wang, Xiaomei Li, Xiaowei Yao, Xin Fu, Xin Su, Xin Zeng, Xinchun Yang, Xiuhong Li, Xuehua Fang, Xutong Wang, Yaming Geng, Yan Yan, Yanek Pépin-Dubois, Yanfu Wang, Yang Wang, Yanmeng Tian, Yaping Huang, Yechen Han, Yesenia Zambrano, Yi-Hsuan Yang, Ying Tung Sia, Yining Yang, Yitong Ma, Yolayfi Peralta, Yongjian Wu, Yu Kunwu, Yu Zhao, Yudong Peng, Yueh-Hung Lin, Yulan Zhao, Yumei Dong, Yunhai Zhao, Yutthaphan Wannasopha, Yvonne Taul, Zakir Sahul, Zalina Kudzoeva, Zbigniew Kalarus, Zeljko Z Markovic, Zhen Huang, Zheng Ji, Zhenyu Liu, Zhou Yue, Zhulin Zhang, Zhuxi Li, Zile Singh Meharwal, Ziliang Bai, Zixiang Yu, Zohra Huda, Zoltan Davidovits
- Subjects
Male ,Cardiac Catheterization ,Computed Tomography Angiography ,medicine.medical_treatment ,Myocardial Ischemia ,Coronary Disease ,Coronary Artery Disease ,Kaplan-Meier Estimate ,030204 cardiovascular system & hematology ,Coronary Angiography ,ISCHEMIA Research Group ,law.invention ,Angina ,Coronary artery disease ,0302 clinical medicine ,Randomized controlled trial ,law ,Cardiovascular Disease ,Myocardial Revascularization ,030212 general & internal medicine ,Coronary Artery Bypass ,11 Medical and Health Sciences ,Cardiac catheterization ,General Medicine ,Middle Aged ,humanities ,Cardiovascular Diseases ,Cardiology ,Female ,Human ,medicine.medical_specialty ,Ischemia ,Article ,03 medical and health sciences ,Geriatric cardiology ,Percutaneous Coronary Intervention ,General & Internal Medicine ,Internal medicine ,medicine ,Humans ,Angina, Unstable ,Aged ,business.industry ,Coronary Artery Bypa ,Percutaneous coronary intervention ,Bayes Theorem ,medicine.disease ,Heart failure ,Quality of Life ,business - Abstract
BACKGROUND: Among patients with stable coronary disease and moderate or severe ischemia, whether clinical outcomes are better in those who receive an invasive intervention plus medical therapy than in those who receive medical therapy alone is uncertain. METHODS: We randomly assigned 5179 patients with moderate or severe ischemia to an initial invasive strategy (angiography and revascularization when feasible) and medical therapy or to an initial conservative strategy of medical therapy alone and angiography if medical therapy failed. The primary outcome was a composite of death from cardiovascular causes, myocardial infarction, or hospitalization for unstable angina, heart failure, or resuscitated cardiac arrest. A key secondary outcome was death from cardiovascular causes or myocardial infarction. RESULTS: Over a median of 3.2 years, 318 primary outcome events occurred in the invasive-strategy group and 352 occurred in the conservative-strategy group. At 6 months, the cumulative event rate was 5.3% in the invasive-strategy group and 3.4% in the conservative-strategy group (difference, 1.9 percentage points; 95% confidence interval [CI], 0.8 to 3.0); at 5 years, the cumulative event rate was 16.4% and 18.2%, respectively (difference, -1.8 percentage points; 95% CI, -4.7 to 1.0). Results were similar with respect to the key secondary outcome. The incidence of the primary outcome was sensitive to the definition of myocardial infarction; a secondary analysis yielded more procedural myocardial infarctions of uncertain clinical importance. There were 145 deaths in the invasive-strategy group and 144 deaths in the conservative-strategy group (hazard ratio, 1.05; 95% CI, 0.83 to 1.32). CONCLUSIONS: Among patients with stable coronary disease and moderate or severe ischemia, we did not find evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of ischemic cardiovascular events or death from any cause over a median of 3.2 years. The trial findings were sensitive to the definition of myocardial infarction that was used. (Funded by the National Heart, Lung, and Blood Institute and others; ISCHEMIA ClinicalTrials.gov number, NCT01471522.).
- Published
- 2020
- Full Text
- View/download PDF
44. The Method of Pose Judgment of Potential Motion Damage in 3D Image Analysis
- Author
-
Liping Gao
- Subjects
Medicine (General) ,Computer science ,Movement ,Biomedical Engineering ,Health Informatics ,Motion (physics) ,Judgment ,Motion ,Imaging, Three-Dimensional ,R5-920 ,Image Processing, Computer-Assisted ,Medical technology ,Humans ,Computer vision ,R855-855.5 ,Analysis method ,Data collection ,Simulation test ,business.industry ,Work (physics) ,Range (mathematics) ,3d image ,Surgery ,Artificial intelligence ,Error prevention ,business ,Research Article ,Biotechnology - Abstract
Objective. This work aimed to study the posture judgment method of 3D image analysis of potential motion damage. Methods. The motion damage collection was implemented by the 3D image analysis method, and 3D image data were adopted to identify the motion damage data. Moreover, 3D image acquisition technology was adopted to analyze the model of potential motion damage and analyze the simulation judgment result of potential motion damage. Specifically, it included simulation parameters, motion damage posture collection effect, damage detection speed at the collection point, damage accuracy, and damage degree. Results. (1) The analysis of the damage monitoring speed at multiple collection points of the athletes in the sports environment confirmed that the range of changes in different time periods was different, and the changes showed a fast to slow to fast trend. (2) The 3D image analysis had high accuracy in analyzing the posture of potential motion damage, which rationalized the evolution of injuries. (3) The degree of motion damage under a 3D image changed from rising to gradual, which was in line with the theoretical results (all p
- Published
- 2021
- Full Text
- View/download PDF
45. Association of High-Affinity Autoantibodies With Type 1 Diabetes High-Risk HLA Haplotypes
- Author
-
Peter A. Gottlieb, Taylor K. Armstrong, Liping Yu, Andrea K. Steck, Hali C. Broncucia, Taylor M. Triolo, and Laura Pyle
- Subjects
Adult ,Male ,endocrine system ,medicine.medical_specialty ,Adolescent ,Insulin Antibodies ,Endocrinology, Diabetes and Metabolism ,Clinical Biochemistry ,Human leukocyte antigen ,medicine.disease_cause ,Biochemistry ,Autoimmunity ,Young Adult ,HLA-DR3 Antigen ,Endocrinology ,HLA Antigens ,Diabetes mellitus ,Internal medicine ,Genotype ,HLA-DR4 Antigen ,medicine ,Humans ,Child ,Online Only Articles ,Autoantibodies ,Type 1 diabetes ,Glutamate Decarboxylase ,business.industry ,Biochemistry (medical) ,Haplotype ,Autoantibody ,medicine.disease ,Titer ,Diabetes Mellitus, Type 1 ,Haplotypes ,Child, Preschool ,Immunology ,Female ,business - Abstract
Objective Electrochemiluminescence (ECL) assays are high-affinity autoantibody (Ab) tests that are more specific than Abs detected by traditional radiobinding assays (RBA) for risk screening and prediction of progression to type 1 diabetes. We sought to characterize the association of high-risk human leukocyte antigen (HLA) haplotypes and genotypes with ECL positivity and levels in relatives of individuals with type 1 diabetes. Methods We analyzed 602 participants from the TrialNet Pathway to Prevention Study who were positive for at least 1 RBA diabetes-related Ab [glutamic acid decarboxylase autoantibodies (GADA) or insulin autoantibodies (IAA)] and for whom ECL and HLA data were available. ECL and RBA Ab levels were converted to SD units away from mean (z-scores) for analyses. Results Mean age at initial visit was 19.4 ± 13.7 years; 344 (57.1%) were female and 104 (17.3%) carried the high-risk HLA-DR3/4*0302 genotype. At initial visit 424/602 (70.4%) participants were positive for either ECL-GADA or ECL-IAA, and 178/602 (29.6%) were ECL negative. ECL and RBA-GADA positivity were associated with both HLA-DR3 and DR4 haplotypes (all Ps < 0.05), while ECL and RBA-GADA z-score titers were higher in participants with HLA-DR3 haplotypes only (both Ps < 0.001). ECL-IAA (but not RBA-IAA) positivity was associated with the HLA-DR4 haplotype (P < 0.05). Conclusions ECL-GADA positivity is associated with the HLA-DR3 and HLA-DR4 haplotypes and levels are associated with the HLA-DR3 haplotype. ECL-IAA positivity is associated with HLA-DR4 haplotype. These studies further contribute to the understanding of genetic risk and islet autoimmunity endotypes in type 1 diabetes.
- Published
- 2021
- Full Text
- View/download PDF
46. The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
- Author
-
Huijing Feng, Zhengbo Song, Qian Wang, Yiping Zhang, Yi-Bing Xu, Guangyuan Lou, Chunwei Xu, Wen-Bin Gao, Wenxian Wang, Lan Shao, Xingxiang Pu, Xiaodong Gu, Liping Wang, and Siyuan Wang
- Subjects
Oncology ,Cancer Research ,medicine.medical_specialty ,Lung Neoplasms ,Drug-Related Side Effects and Adverse Reactions ,Immune checkpoint inhibitors ,Immunology ,Antineoplastic Agents, Immunological ,Immune system ,Carcinoma, Non-Small-Cell Lung ,Internal medicine ,PD-L1 ,Humans ,Immunology and Allergy ,Medicine ,Lung cancer ,Adverse effect ,Immune Checkpoint Inhibitors ,Retrospective Studies ,Pneumonitis ,biology ,business.industry ,Retrospective cohort study ,Prognosis ,medicine.disease ,Nivolumab ,biology.protein ,Non small cell ,business - Abstract
Patients treated with immune checkpoint inhibitors (ICIs) often experience unique immune-related adverse events (irAEs), and the previous studies demonstrated an association between irAEs and better outcomes in patients with ICI treatment for advanced non-small cell lung cancer (NSCLC). However, the correlation between the occurrence of mild and severe irAEs and prognosis remains unclear. Additionally, little is known regarding the association between the timing of mild and severe irAEs and clinical outcomes. We retrospectively conducted a multicenter study of advanced NSCLC patients treated with ICI monotherapy. Of the 222 patients, 79 patients (35.6%) experienced at least one irAE, and most were of grade 1 or 2 (mild) (26.6%). The most common irAEs were pneumonitis (n = 21, 9.5%) and skin-related adverse reactions (n = 19, 8.6%). The median progression-free survival of all patients treated with ICIs was 3.2 months. Patients experiencing irAEs had a better prognosis than those without such events (6.5 vs. 2.6 months, p = 0.004), and mild irAEs were associated with the best prognosis. The difference in overall survival between mild and severe irAEs was significant (34.3 vs. 17.3 months, p = 0.021). We further analyzed differences between patients with irAEs occurring at 3 or 6 weeks, and found that the earlier the occurrence of mild irAEs, the better the prognosis; however, the opposite was true for severe irAEs. In summary, patients with early occurring mild irAEs showed better clinical outcomes, whereas those with early severe irAEs tended to show poorer clinical outcomes.
- Published
- 2021
- Full Text
- View/download PDF
47. Probabilistic prediction of the spatial distribution of potential key blocks during tunnel surrounding rock excavation
- Author
-
Peng He, Fei Xu, Gang Wang, Sun Shangqu, and Liping Li
- Subjects
Atmospheric Science ,geography ,geography.geographical_feature_category ,business.industry ,Computer science ,Monte Carlo method ,Probabilistic logic ,Structural engineering ,Rockfall ,Earth and Planetary Sciences (miscellaneous) ,Probability distribution ,business ,Rock mass classification ,Joint (geology) ,Discontinuous Deformation Analysis ,Water Science and Technology ,Network model - Abstract
Jointed network simulations tend to be more random in nature due to the uncertainty of rock mass structures. In this paper, a series of jointed network models can be established in batches using Monte Carlo simulation (MSC) and loop iteration. Taking the joints, tunnel profile and their intersections as the edges E and vertices V of graph G, the jointed network model can serve as an unweighted undigraph. Then, the breadth-first search is introduced to search the closed paths around the tunnel profile, such as the potential key blocks. With batch simulation of network models, the spatial distribution characteristics and probability distribution rules of blocks can be automatically analysed during the search process. For comparison, the Laohushan tunnel of the Jinan Belt Expressway in China has been analysed using the breadth-first search, discontinuous deformation analysis method and procedure of “Finding the Key Blocks-Unrolled Tunnel Joint Trace Maps”. Each simulation starts from the same probabilistic model of geometrical parameters of joints but develops differently with different outcomes. The spatial distribution rule of potential key blocks simulated by the aforementioned batch jointed network models is essentially identical to the actual rockfall during tunnel excavation.
- Published
- 2021
- Full Text
- View/download PDF
48. Detection of Body Behavior Characteristics in Sports Training Based on Grey Relational Model
- Author
-
Liping Li and Shishan Zeng
- Subjects
Science (General) ,Article Subject ,Computer Networks and Communications ,business.industry ,Computer science ,Binary image ,Training (meteorology) ,Inter frame ,Pattern recognition ,Image (mathematics) ,Q1-390 ,Equation of time ,Feature descriptor ,Relational model ,T1-995 ,Artificial intelligence ,business ,Technology (General) ,Grey correlation ,Information Systems - Abstract
In order to deal with the problems of low detection accuracy and efficiency existing in traditional detection methods of body behavior characteristics in sports training, this paper proposes a new detection method of body behavior characteristics in sports training based on the grey correlation model. According to this method, the foreground binary image is obtained by the interframe difference method, and the action information and contour information are extracted, firstly. And then, the behavior feature descriptor is obtained. After the description of body behavior characteristics in sports training is completed, the grey correlation coefficient is calculated, and the complete observation equation of time delay estimation of image grey value under complex sports training background is established to complete the detection of body behavior characteristics. The experimental results show that, compared with the traditional methods, the detection accuracy and efficiency of the text method can always maintain a high level, indicating that the practical application performance of this method is strong. In fact, the grey analysis does not attempt to find the best solution but does provide techniques for determining a good solution.
- Published
- 2021
- Full Text
- View/download PDF
49. Pose Estimation under Visual Sensing Technology and Its Application in Art Design
- Author
-
Bing Song, Meng Li, and Liping Lou
- Subjects
Article Subject ,Art design ,Computer science ,business.industry ,ComputingMethodologies_IMAGEPROCESSINGANDCOMPUTERVISION ,Control and Systems Engineering ,T1-995 ,Computer vision ,Artificial intelligence ,Electrical and Electronic Engineering ,business ,Instrumentation ,Pose ,Technology (General) - Abstract
The study is aimed at solving the problem of large measurement errors caused by the binocular camera in traditional 3D art design, which leads to inaccurate 3D information of the target. The contour information extraction in the process of human motion pose reconstruction is easily affected by the noise in the image. Therefore, a binocular stereo vision system is built first and it integrates image acquisition, camera calibration, and image processing. The dedistortion method is used to process the image because it can reduce errors. Second, a three-dimensional human motion pose reconstruction model is implemented, the Gaussian template is used to remove the noise in the image frame, and the change detection template (CDM) is used to solve the problem of background “exposure” and “occlusion.” Finally, simulation experiments are designed to verify the system and model designed. Since the research on the application of pose estimation based on visual sensing technology in art design is still blank, such research has great significance and provides a reference for the research in the field. The literature analysis is used to expound and analyze the application of pose estimation based on visual sensing technology in visual communication design and environmental art design: (1) although the binocular stereo vision system causes some errors in the measurement, the overall error is controlled within 2% and the accuracy is high, which proves that it can be applied to the acquisition of three-dimensional information of the target in art design; (2) there is a high degree of fitting between the video sequence data created by the three-dimensional human motion pose reconstruction model designed and the real motion data, which indicates that this method has high accuracy in processing image sequences and the feasibility of applying it to human pose reconstruction in three-dimensional art design is high; (3) through the analysis of the existing literature, it is found that most of the current visual-based attitude assessment studies are carried out by using network cameras combined with computers, and the quality of the obtained images is low. The combination of binocular stereo sensor and attitude estimation technology can be applied to the design of advertising, animation, games, and packaging, making the behavior of virtual characters in animation and games more vivid. The combination provides convenience for the collection of environmental spatial information and object attitude information, the formulation of a design scheme, and real-time monitoring of construction in environmental art design. The purpose of this study is to provide an important theoretical basis for the technical upgrading of art design.
- Published
- 2021
- Full Text
- View/download PDF
50. Attributes of product advantage and choices for manufacturer–retailer formal governance: the case of new product launch
- Author
-
Songyue Zheng, Pianpian Yang, and Liping Qian
- Subjects
business.industry ,Corporate governance ,New product development ,General Medicine ,Product (category theory) ,business ,Industrial organization - Abstract
PurposeThis study examined how the technological (tech) advantage and market advantage of new products influence the level of formal channel governance and, in turn, affect the success of new products in the presence of relational governance.Design/methodology/approachThe hypotheses are tested using the partial least squares approach to analyse survey data collected from 392 retailers of customer goods in China.FindingsThe results indicate that tech advantage and market advantage lead to an increase in retailers' transaction-specific investments (TSIs) and contract explicitness, respectively; the positive effect of market advantage on a retailer's TSIs will gradually decrease and will even become negative beyond a certain point. The relational governance mechanism can substitute for the effects of contract explicitness on improving new product success.Originality/valueThis research provides a new perspective for understanding new product advantage and exerts an initial effort to empirically distinguish between tech advantage and market advantage. It enriches the innovation literature by examining the governance of new product launches through retailers and explores the effects of formal and informal governance on channel cooperation performance in the new product launch stage.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.